Factsheets: 📈 Markets 🎯 Mandates 📋 Case Studies 📘 SOPs 🏛 Trade Bodies 🏙 Cities 🌍 Countries 🇮🇳 Indian States ⚓ Ports 🏛️ SEZs 🤝 Blocs 📜 FTAs 🛤 Corridors ⚙ Verticals 📦 Commodities 🧮 Tools ⚖️ Compare 🌐 Bilateral Hubs 📚 Library 🎓 Academy ✍️ Essays 📰 Blog 🔤 Lexicon ❓ FAQ 📡 Authority Sources ⚡ Daily Pulse 📰 Topic Briefs 📡 Google Signals 🧭 Scope Scape cron-refreshed
Live factsheets · cron-refreshed

All factsheets at a glance

Command center →
📈 Markets
554
global + India · commodities + indices + shares + crypto + FX
minute
🎯 Mandates
69
sell + buy · live
daily
📋 Case Studies
37
closed · anonymised
weekly
📘 SOPs
42
step-by-step playbooks
weekly
🏛 Trade Bodies
1,350
291 baseline + 1059 hand-curated
monthly
🏙 Cities
1,584
global atlas
daily
🌍 Countries
184
multilateral
weekly
🇮🇳 Indian States
37
state trade profiles
monthly
⚓ Ports
52
global maritime gateways
monthly
🏛️ SEZs
31
global SEZ profiles
monthly
🤝 Blocs
28
tracked
monthly
📜 FTAs
526
active or signed
monthly
🛤 Corridors
37
tracked
monthly
⚙ Verticals
50
sectoral
weekly
📦 Commodities
51
HS-coded intelligence
monthly
🧮 Tools
105
free utilities
monthly
⚖️ Compare
pairwise combinations
monthly
🌐 Bilateral Hubs
184
India × every country
weekly
📚 Library
140
interconnected
monthly
🎓 Academy
25
trade education
monthly
✍️ Essays
30
long-form analysis
monthly
📰 Blog
34
editorial
weekly
🔤 Lexicon
312
glossary terms
monthly
❓ FAQ
155
curated Q&A
monthly
📡 Authority Sources
140
curated · vetted
hourly
⚡ Daily Pulse
145
rolling 5,000 cap
hourly
📰 Topic Briefs
29
permanent archive
hourly
📡 Google Signals
Trends·News·Alerts
hourly
🧭 Scope Scape
61
11 scopes
hourly
Weekly factsheet · sops
Last refresh: 58 days ago
Next:
SOPs
42
step-by-step playbooks
Categories
12
export · import · compliance

Vertical SOPs — India to EU/World

1092 SME-level Standard Operating Procedures — one per vertical. Prerequisites, step-by-step process, key documents, certifications, common mistakes, and AJG tools. The most detailed India export SOPs available anywhere.

Clear

20 SOPs found for "pharma"

Pharma v1.0 · 2026-04-01

Pharmaceutical and API Export — India to EU

India is the world' largest generic pharmaceutical exporter and the EU is its largest pharma market by value. This SOP covers the complete pathway from Indian ...

6 steps
↓ Expand

India is the world' largest generic pharmaceutical exporter and the EU is its largest pharma market by value. This SOP covers the complete pathway from Indian WHO-GMP facility to EU-licensed finished dose or API supply — EU GMP certification, EDQM CEP filing, marketing authorisation, export documentation, and pharmacovigilance obligations.

Prerequisites

  • WHO-GMP certificate from CDSCO for the manufacturing facility and product types
  • EU GMP certificate from a recognised EU competent authority (MHRA, BfArM, AGES, or ANSM) — mandatory for any API or FDF supplied to EU-licensed products
  • RCMC from PHARMEXCIL India — enables DGFT-authorised Certificate of Origin for pharma exports
  • IEC from DGFT and LUT on GSTN portal for zero-rated GST on pharmaceutical exports
  • ECGC Standard Policy for EU pharma buyer receivables protection
  • IP freedom-to-operate clearance for any patented molecule or process used in EU-destined product

Step-by-Step Process

1 EU Regulatory Pathway Selection 4-8 weeks · Regulatory Affairs Director
  • Determine product type: API or Finished Dose Formulation; for APIs choose between EDQM CEP (pharmacopoeial molecules) or ASMF (non-pharmacopoeial or confidential process)
  • For FDFs: select marketing authorisation procedure — national (single EU member state), MRP (mutual recognition), DCP (decentralised simultaneous multi-state), or EMA centralised (biotechnology and new active substances)
  • Conduct EU regulatory gap analysis versus Indian CTD dossier — EDQM format requirements for CEP differ from ICH CTD; EMA expects Module 3 for FDFs in eCTD format
  • For generic FDFs: bioequivalence study must use EU-licensed reference product purchased in EU — US or Indian reference product is NOT accepted by EMA or EU NCAs
2 EU GMP Certification 12-24 months · QA Director
  • Engage EU regulatory consultant or QP (Qualified Person) in target EU member state to assess GMP status versus EU GMP Annex 1-16 requirements; Annex 11 (computerised systems) and Annex 15 (qualification and validation) are most commonly deficient in Indian facilities
  • Apply for EU GMP inspection through CDSCO joint inspection programme or directly through EU national competent authority; inspection fee EUR 5,000-25,000 depending on NCA and facility complexity
  • Data integrity is the highest-priority inspection focus for all EU GMP inspectors visiting Indian pharmaceutical facilities — implement complete audit trail systems on all analytical instruments and LIMS before inviting EU inspection
  • Prepare for unannounced EU GMP inspections from 2026 — EU GMP inspection modernisation programme includes unannounced visits to high-risk sites; have facility at inspection-ready standard at all times
3 EDQM CEP Application 12-18 months · Regulatory Affairs Manager
  • Prepare CEP dossier in EDQM application format (not ICH CTD — EDQM has its own specific module structure): synthesis route, starting materials, intermediates, in-process controls, specifications and analytical validation data, stability data from three production batches under ICH Q1A conditions
  • Submit through EDQM online CEP application portal — application fee EUR 17,060 for new CEP applications; payment by bank transfer to EDQM Strasbourg account
  • EDQM assessment timeline: 12-18 months from validated submission date; EDQM sends Technical Questions (TQs) and Objections (OBJ) during review — respond within specified EDQM deadlines or application lapses without refund
  • CEP once granted is portable — any EU Marketing Authorisation Holder can reference your CEP in their MA dossier without requiring your confidential synthesis data; build a pipeline of EU MAH relationships to leverage your CEP across maximum EU product registrations
4 Marketing Authorisation 12-36 months · Regulatory Affairs Director
  • Most resource-efficient EU entry: licensing agreement with an EU MAH who holds the MA and handles EU pharmacovigilance, distribution, and regulatory maintenance; Indian manufacturer supplies bulk or finished product under supply agreement; EU MAH pays on ex-works or CIF basis
  • If pursuing own MA via DCP: submit simultaneously in reference member state and 3-5 concerned member states; NCA assessment 12-15 months; EU Qualified Person for Pharmacovigilance (QPPV) must be named before application and be resident in EU with pharmacovigilance qualification
  • Variation management: post-authorisation changes to any aspect of the MA (manufacturing site, specification, supplier) require variation filing before implementation; Type IA and IB changes are minor; Type II are major requiring NCA assessment before implementation
  • EUDRP (European Drug Regulatories Platform): Indian pharma companies should register on EUDRP for electronic submission of regulatory dossiers — all EU NCAs now accept eCTD submissions through EUDRP
5 Export Documentation and Shipment 2-5 days per shipment · Export Documentation Manager
  • Commercial invoice: must state INN (International Non-proprietary Name), HS code (Chapter 30 for FDFs, Chapter 29 for most APIs), batch number, analytical release date, and quantity in both units and kg
  • PHARMEXCIL COO for EU GSP preference — reduces EU duty from MFN to GSP rate for applicable pharma HS codes; COO application filed online with PHARMEXCIL 3 days before shipment; requires invoice, B/L draft, and packing list
  • WHO-GMP certificate and Certificate of Analysis (CoA) per batch — EU importer requires these for GDP receiving inspection and to satisfy their Qualified Person batch release obligation
  • GDP cold chain documentation: for 2-8°C products — validated packaging qualification data, temperature logger certificate for each shipment, and courier GDP compliance certificate
6 EU Pharmacovigilance and Post-Market Obligations Ongoing · Pharmacovigilance Officer
  • If holding own EU MA: appoint QPPV based in EU; QPPV is responsible for establishing and maintaining EU pharmacovigilance system, submitting PSURs (Periodic Safety Update Reports) to EMA/NCA on product lifecycle schedule, and reporting expedited ADRs within regulatory timelines
  • Expedited reporting: fatal or life-threatening unexpected serious adverse reactions — 15 calendar days from first awareness; all other serious unexpected reactions — 90 calendar days; non-serious reactions — not expedited
  • PSUR schedule: newly authorised products — annually for first 2 years; established products with single substance — every 3 years; submit through EMA EVWEB portal to EudraVigilance database
  • Post-market surveillance: EU-licensed pharmaceuticals must monitor spontaneous adverse event reports from EU healthcare professionals and patients; maintain dedicated pharmacovigilance database and trained staff

Key Documents

  • WHO-GMP Certificate (CDSCO)
  • EU GMP Certificate (EU NCA)
  • EDQM CEP or ASMF reference letter
  • Certificate of Analysis per batch
  • PHARMEXCIL Certificate of Origin
  • GDP temperature-validated transport documentation
  • EU Marketing Authorisation or EU MAH supply agreement

Key Certifications

  • EU GMP Certificate
  • EDQM CEP (for APIs)
  • WHO Prequalification (for WHO tender market access)
  • ISO 15378 (pharmaceutical primary packaging)

Common Mistakes

  • Assuming WHO-GMP equals EU GMP — EU inspectors have additional and different requirements especially on data integrity and computerised systems; budget separate EU GMP investment
  • Shipping API to EU without CEP or referenced ASMF — EU manufacturers cannot legally use unregistered APIs in EU-licensed medicines; customs will not detain the shipment but the EU buyer will reject it on QP release
  • Missing the 21-day LC document presentation window for complex pharma documentation sets — calculate maximum presentation date backwards from sailing date and set internal milestones
  • Not maintaining GDP temperature records during transport — EU GDP guidelines require documented temperature excursion management for every shipment; missing records can result in EU QP batch rejection

AJG Tools for This Vertical

AJG FTA Savings Estimator — EU GSP duty saving calculation for your pharma HS code AJG EU Regulatory Partner Network — EDQM, BfArM, MHRA consultant introductions for EU GMP certification AJG EU Pharma Distribution Partner Pipeline — EU licensed distributors and MAHs seeking Indian generic supply
Submit Pharma Mandate →
Cold Chain Logistics v1.0 · 2026-04-01

Cold Chain Logistics Services — India to EU

Indian cold chain logistics providers manage temperature-controlled storage and transport for pharmaceutical, agro-food, and chemical exports. For pharmaceutica...

6 steps
↓ Expand

Indian cold chain logistics providers manage temperature-controlled storage and transport for pharmaceutical, agro-food, and chemical exports. For pharmaceutical exports, EU GDP (Good Distribution Practice) compliance is mandatory. For food exports, HACCP and ISO 22000 cover the cold chain. This SOP covers cold chain logistics service delivery for India-EU trade.

Prerequisites

  • IEC from DGFT and relevant EPC RCMC
  • ISO 9001:2015 certification from an accredited certification body
  • LUT filed on GSTN portal for zero-rated GST on exports
  • ECGC Standard Policy in place for EU receivables protection
  • Sector-specific EU product compliance assessment — CE marking, REACH, or other applicable regulations
  • AJG mandate agreement for counterparty identification and introduction

Step-by-Step Process

1 Market and Regulatory Assessment 4-8 weeks · Business Development Manager
  • Identify all applicable EU product regulations for your specific product or service category — EU TARIC for duty and anti-dumping status; EU product safety Blue Guide for applicable CE marking directives; ECHA database for REACH obligations
  • Conduct EU market sizing and competitive analysis — identify market segments, target buyer profile, volume requirements, price benchmarks, and key competitors from India and other supply countries
  • Assess product and facility readiness against EU standards — gap analysis identifying certification and compliance investments required and timeline to EU market entry
  • Calculate FTA savings on your specific HS code — EU GSP rate versus MFN rate, India-UAE CEPA savings, India-Australia ECTA qualifying content verification; use AJG FTA Savings Estimator
2 EU Compliance and Certification Programme 3-12 months depending on sector · QA / Regulatory Manager
  • Close identified compliance gaps systematically: CE marking (select correct directive, conformity assessment route, Notified Body if required), REACH SVHC screening, product-specific testing at ISO 17025 accredited laboratory
  • Prepare EU-compliant commercial documentation: technical data sheets in English and target EU languages, Safety Data Sheets (SDS in CLP format for chemicals), EU labelling artwork for each target EU member state market
  • Engage EU technical partner or consultant where sector-specific EU regulatory expertise is required — CE marking consultant for machinery, REACH consultant for chemicals, GDPR counsel for IT services, food safety consultant for agro-food
  • Obtain EU product liability insurance — critical for any product physically entering EU market; Indian manufacturers without EU establishment must appoint EU Authorised Representative who is the liable party in EU for product liability purposes
3 EU Buyer Identification and Qualification 3-6 months · Sales / Business Development Manager
  • Attend the most relevant EU trade fair for your sector — EEPC Hannover Messe Pavilion for engineering; PHARMEXCIL CPhI Europe for pharma; AEPC Premier Vision for textiles; APEDA SIAL Paris for agro-food; EPCH Ambiente Frankfurt for handicrafts; AJG pre-schedules B2B meetings with qualified buyers at all major sector fairs
  • Prepare commercial capability statement tailored to EU buyer requirements — machine capabilities and tolerances (engineering), GMP and CEP status (pharma), certifications (all sectors), production capacity, lead times, minimum order quantities, and reference customers
  • Submit physical product samples or service capability demonstration with full technical specification sheet — EU buyers evaluate samples against their technical requirements before entering commercial discussion; sample quality determines whether commercial conversation happens
  • Register company profile on EU B2B platforms — Europages, WLSP (for pharma), REACH registered substance database (for chemicals) — EU procurement teams actively search these platforms for Indian suppliers
4 Commercial Negotiation and Contract 4-8 weeks · Commercial / Legal Manager
  • Negotiate and agree: Incoterm (recommend CIF for first EU shipments — gives more control over shipping quality and insurance), unit price (build from FOB cost + freight + insurance + EU duty + delivery; provide EU buyer with landed cost model), payment terms (LC sight for first 2-3 orders with new buyers; progress to D/P or open account with ECGC once 12 months payment history established), delivery schedule (include 10-15% buffer time for production variance and shipping transit variability)
  • Structure commercial contract with EU-appropriate provisions: governing law (typically EU buyer country law for EU sales; Indian law for supply agreements governed from India), dispute resolution (ICC arbitration recommended for cross-border trade disputes above USD 100,000), IP ownership clause, product liability and indemnity, force majeure definition (include pandemic, port strikes, regulatory changes), and for IT/services: GDPR Data Processing Agreement incorporated by reference
  • Agree sample approval process in writing before production commences — golden sample, pre-production sample approval, and in-process inspection milestones; written buyer approval at each stage is essential evidence if quality dispute arises post-shipment
  • Document AJG commission structure in the mandate agreement before counterparty introduction — AJG commission is paid by both principals independently on completion of transaction; commission is fully transparent to both parties
5 Order Execution, Quality Control, and Pre-Shipment Throughout production cycle · Production / QA Manager
  • Establish production schedule against buyer' delivery requirements with minimum 10% time buffer for quality rejection and re-work; provide buyer with weekly production status updates for orders above USD 50,000
  • In-process quality inspections at critical production milestones — fabric inspection (textiles), dimensional check at machining stage (engineering), analytical testing at synthesis stage (chemicals/pharma) — do not rely on finished goods inspection alone
  • Pre-shipment inspection: if buyer specifies third-party inspection (SGS, Bureau Veritas, Intertek, TUV SUD), coordinate inspection booking 5 working days before intended loading date; inspection certificate is typically required before buyer releases LC or authorises payment
  • Complete batch/lot documentation: maintain complete traceability records from raw material receipt through to finished goods dispatch — lot number, supplier certificates, in-process test results, final product test results, and packing details — essential for EU recall procedures and RAPEX/RASFF compliance
6 Shipment, Documentation, FTA Optimisation, and Post-Export Incentives 2-4 days per shipment · Export / Finance Manager
  • Prepare complete export documentation set per LC requirements or buyer specification: commercial invoice (HS code, Incoterm, unit price, extended value, payment terms, country of origin), packing list (net weight, gross weight, dimensions, marks and numbers per carton), Bill of Lading (negotiable, 3/3 originals, correct notify party per LC, on-board notation, clean B/L), EPC Certificate of Origin (sector-specific — EEPC for engineering, PHARMEXCIL for pharma, APEDA for agro-food — apply 3 working days before shipping date)
  • FTA optimisation: present COO to EU importer for EU GSP preference claiming at EU customs — importer declares preference on EU import declaration; verify that EU importer is actually claiming the preference (many do not, leaving savings unclaimed)
  • File RoDTEP claim on ICEGATE at time of shipping bill processing — ensure correct HS code and RoDTEP rate are applied; scrip issued by DGFT usable for import duty payment on capital goods or transferable in scrip market
  • Post-export: GST refund claim on GSTN portal within 2 years of export; ECGC premium payment per shipping quarter; FIRC (Foreign Inward Remittance Certificate) from bank on receipt of each EU payment — retain FIRC for FEMA compliance and SEIS entitlement claims

Key Documents

  • ISO 9001 Certificate
  • EPC Certificate of Origin for EU GSP preference
  • ECGC Policy Certificate and Buyer Exposure Limit
  • Commercial Invoice and Packing List
  • Bill of Lading (negotiable, full set 3/3)
  • Pre-shipment Inspection Certificate (if buyer-required)
  • Product compliance certificate (CE, test report, or applicable standard)

Key Certifications

  • ISO 9001:2015
  • CE Marking (product-specific where applicable)
  • EPC RCMC (relevant Export Promotion Council)
  • ECGC Standard Policy

Common Mistakes

  • Attempting EU market entry without verifying applicable EU product regulations — non-compliant goods are seized at EU Border Inspection Posts
  • Not obtaining EPC Certificate of Origin before shipment — EU GSP preference is permanently lost for that consignment; there is no retroactive COO
  • Offering open account payment to first-time EU buyers without ECGC Buyer Exposure Limit — buyer default risk on new relationships is highest
  • Underestimating EU compliance and certification timeline — CE marking, product testing, and accreditation typically require 6-12 months; plan this before committing to EU buyer delivery schedules

AJG Tools for This Vertical

AJG FTA Savings Estimator — EU GSP and applicable FTA duty savings for your HS code AJG EU Buyer Pipeline — sector-specific EU buyer introductions and B2B mandate facilitation AJG ECGC Policy Structuring — optimal buyer exposure limits and cover for EU buyer portfolio
Submit Cold Chain Logistics Mandate →
Pharma v1.0 · 2026-04-27

Pharma export SOP — India to Netherlands

End-to-end pathway for Pharma exports from India to Netherlands. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, ...

6 steps
↓ Expand

End-to-end pathway for Pharma exports from India to Netherlands. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, export documentation (commercial invoice, packing list, certificate of origin, B/L, insurance certificate), Incoterm-aligned pricing, payment mechanics, lead-time management, and post-shipment compliance for the Netherlands regime.

Prerequisites

  • IEC issued by DGFT for the manufacturing entity
  • RCMC from the relevant Export Promotion Council for Pharma
  • EU GMP / FDA 21 CFR 211 / WHO-GMP compliance evidence package
  • Netherlands importer pre-qualification + freight forwarder appointment
  • ECGC Standard Policy or equivalent receivables cover for new buyer
  • LUT bond filed on GSTN for zero-rated GST on the export

Step-by-Step Process

1 Regulatory pathway selection 3-8 weeks · Regulatory Affairs
  • Confirm HS classification across CN8 / TARIC for Pharma consignment
  • Map Netherlands import regime: MFN duty, GSP eligibility, FTA preference, anti-dumping/CVD exposure
  • Identify EU GMP / FDA 21 CFR 211 / WHO-GMP as primary regulatory stack; build evidence dossier 90 days ahead of first shipment
  • Engage local Netherlands regulatory consultant if novel-substance or MA-type filings are required
2 Manufacturing readiness 4-16 weeks · QA Director
  • Audit facility against EU GMP / FDA 21 CFR 211 / WHO-GMP; remediate gaps before pre-shipment inspection
  • Validate analytical methods per ICH Q2 / equivalent for Pharma
  • Stability data 3 commercial batches under ICH Q1A long-term + accelerated conditions
  • Document control system aligned with EU GMP Annex 11 / FDA Part 11 expectations
3 Buyer + commercial pre-qualification 2-6 weeks · Sales Director
  • Issue NDA + ' . Netherlands . ' KYC pack to ' . Netherlands . ' buyer; receive corporate registration + VAT/EORI evidence
  • Negotiate Incoterm + payment terms; align on LC/D-P/Open-account based on relationship maturity
  • Procure ECGC Standard Policy at 0.15-0.30% premium for new Netherlands buyer exposure
  • Lock currency + price-validity per quarterly hedging policy
4 Production + pre-shipment inspection 4-24 weeks · Operations
  • Production per validated MBR; release per QA SOPs; CoA per batch in EU 10204 3.1 format
  • Pre-shipment inspection by Bureau Veritas / SGS / Intertek per Netherlands import-permit requirement
  • Container stuffing supervised + sealed; container photos + weighbridge slip captured
  • CBAM embedded-emissions data computed if applicable per EU Regulation 2023/956
5 Export documentation + customs clearance 3-7 days · Export Documentation
  • Commercial invoice + packing list + COO from PHARMEXCIL/EEPC/AEPC/etc
  • Shipping bill + RoDTEP claim + DBK claim filed on ICEGATE
  • B/L draft amended + final telex release; copies released against payment per LC terms
  • CIF/DAP marine cargo insurance ICC(A) for full invoice value + 10%
6 Post-shipment + working capital recovery 30-180 days · Finance + QA
  • Bank realisation certificate (BRC) within 9 months of shipment per FEMA
  • Apply RoDTEP 1.5% + DBK Schedule II band; FTA preference verification through TARIC; CBAM exposure assessed for relevant chapters
  • GST refund on accumulated ITC filed quarterly via RFD-01
  • Buyer feedback + claims review; corrective action for any quality / paperwork issue within 30 days

Key Documents

  • IEC
  • RCMC
  • Commercial Invoice
  • Packing List
  • Certificate of Origin
  • Bill of Lading
  • Marine Cargo Insurance Certificate
  • EU GMP / FDA 21 CFR 211 / WHO-GMP Certificate
  • CoA
  • Shipping Bill
  • BRC

Key Certifications

  • EU GMP / FDA 21 CFR 211 / WHO-GMP
  • ISO 9001:2015
  • ISO 14001:2015
  • SA8000

Common Mistakes

  • Assuming Indian quality standards equal Netherlands regulatory expectations — always engage local consultant
  • Missing CBAM transitional reports for relevant HS chapters — quarterly filing now mandatory
  • Insufficient pre-shipment inspection — recovery cost on Netherlands QC rejection is 4-7x avoidance cost
  • RoDTEP filing forgetfulness — 1.5-4% margin literally lost forever after the 60-day window

AJG Tools for This Vertical

AJG FTA Savings Estimator — calculates duty saving on the relevant FTA preference AJG Pharma Compliance Pack — pre-built evidence file aligned to EU GMP / FDA 21 CFR 211 / WHO-GMP AJG Netherlands Buyer Pre-qualification — KYC + reference checks
Submit Pharma Mandate →
Pharma v1.0 · 2026-04-27

Pharma export SOP — India to Spain

End-to-end pathway for Pharma exports from India to Spain. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, export...

6 steps
↓ Expand

End-to-end pathway for Pharma exports from India to Spain. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, export documentation (commercial invoice, packing list, certificate of origin, B/L, insurance certificate), Incoterm-aligned pricing, payment mechanics, lead-time management, and post-shipment compliance for the Spain regime.

Prerequisites

  • IEC issued by DGFT for the manufacturing entity
  • RCMC from the relevant Export Promotion Council for Pharma
  • EU GMP / FDA 21 CFR 211 / WHO-GMP compliance evidence package
  • Spain importer pre-qualification + freight forwarder appointment
  • ECGC Standard Policy or equivalent receivables cover for new buyer
  • LUT bond filed on GSTN for zero-rated GST on the export

Step-by-Step Process

1 Regulatory pathway selection 3-8 weeks · Regulatory Affairs
  • Confirm HS classification across CN8 / TARIC for Pharma consignment
  • Map Spain import regime: MFN duty, GSP eligibility, FTA preference, anti-dumping/CVD exposure
  • Identify EU GMP / FDA 21 CFR 211 / WHO-GMP as primary regulatory stack; build evidence dossier 90 days ahead of first shipment
  • Engage local Spain regulatory consultant if novel-substance or MA-type filings are required
2 Manufacturing readiness 4-16 weeks · QA Director
  • Audit facility against EU GMP / FDA 21 CFR 211 / WHO-GMP; remediate gaps before pre-shipment inspection
  • Validate analytical methods per ICH Q2 / equivalent for Pharma
  • Stability data 3 commercial batches under ICH Q1A long-term + accelerated conditions
  • Document control system aligned with EU GMP Annex 11 / FDA Part 11 expectations
3 Buyer + commercial pre-qualification 2-6 weeks · Sales Director
  • Issue NDA + ' . Spain . ' KYC pack to ' . Spain . ' buyer; receive corporate registration + VAT/EORI evidence
  • Negotiate Incoterm + payment terms; align on LC/D-P/Open-account based on relationship maturity
  • Procure ECGC Standard Policy at 0.15-0.30% premium for new Spain buyer exposure
  • Lock currency + price-validity per quarterly hedging policy
4 Production + pre-shipment inspection 4-24 weeks · Operations
  • Production per validated MBR; release per QA SOPs; CoA per batch in EU 10204 3.1 format
  • Pre-shipment inspection by Bureau Veritas / SGS / Intertek per Spain import-permit requirement
  • Container stuffing supervised + sealed; container photos + weighbridge slip captured
  • CBAM embedded-emissions data computed if applicable per EU Regulation 2023/956
5 Export documentation + customs clearance 3-7 days · Export Documentation
  • Commercial invoice + packing list + COO from PHARMEXCIL/EEPC/AEPC/etc
  • Shipping bill + RoDTEP claim + DBK claim filed on ICEGATE
  • B/L draft amended + final telex release; copies released against payment per LC terms
  • CIF/DAP marine cargo insurance ICC(A) for full invoice value + 10%
6 Post-shipment + working capital recovery 30-180 days · Finance + QA
  • Bank realisation certificate (BRC) within 9 months of shipment per FEMA
  • Apply RoDTEP 3.1% + DBK Schedule II band; FTA preference verification through TARIC; CBAM exposure assessed for relevant chapters
  • GST refund on accumulated ITC filed quarterly via RFD-01
  • Buyer feedback + claims review; corrective action for any quality / paperwork issue within 30 days

Key Documents

  • IEC
  • RCMC
  • Commercial Invoice
  • Packing List
  • Certificate of Origin
  • Bill of Lading
  • Marine Cargo Insurance Certificate
  • EU GMP / FDA 21 CFR 211 / WHO-GMP Certificate
  • CoA
  • Shipping Bill
  • BRC

Key Certifications

  • EU GMP / FDA 21 CFR 211 / WHO-GMP
  • ISO 9001:2015
  • ISO 14001:2015
  • SA8000

Common Mistakes

  • Assuming Indian quality standards equal Spain regulatory expectations — always engage local consultant
  • Missing CBAM transitional reports for relevant HS chapters — quarterly filing now mandatory
  • Insufficient pre-shipment inspection — recovery cost on Spain QC rejection is 4-7x avoidance cost
  • RoDTEP filing forgetfulness — 1.5-4% margin literally lost forever after the 60-day window

AJG Tools for This Vertical

AJG FTA Savings Estimator — calculates duty saving on the relevant FTA preference AJG Pharma Compliance Pack — pre-built evidence file aligned to EU GMP / FDA 21 CFR 211 / WHO-GMP AJG Spain Buyer Pre-qualification — KYC + reference checks
Submit Pharma Mandate →
Pharma v1.0 · 2026-04-27

Pharma export SOP — India to UAE

End-to-end pathway for Pharma exports from India to UAE. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, export d...

6 steps
↓ Expand

End-to-end pathway for Pharma exports from India to UAE. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, export documentation (commercial invoice, packing list, certificate of origin, B/L, insurance certificate), Incoterm-aligned pricing, payment mechanics, lead-time management, and post-shipment compliance for the UAE regime.

Prerequisites

  • IEC issued by DGFT for the manufacturing entity
  • RCMC from the relevant Export Promotion Council for Pharma
  • EU GMP / FDA 21 CFR 211 / WHO-GMP compliance evidence package
  • UAE importer pre-qualification + freight forwarder appointment
  • ECGC Standard Policy or equivalent receivables cover for new buyer
  • LUT bond filed on GSTN for zero-rated GST on the export

Step-by-Step Process

1 Regulatory pathway selection 3-8 weeks · Regulatory Affairs
  • Confirm HS classification across CN8 / TARIC for Pharma consignment
  • Map UAE import regime: MFN duty, GSP eligibility, FTA preference, anti-dumping/CVD exposure
  • Identify EU GMP / FDA 21 CFR 211 / WHO-GMP as primary regulatory stack; build evidence dossier 90 days ahead of first shipment
  • Engage local UAE regulatory consultant if novel-substance or MA-type filings are required
2 Manufacturing readiness 4-16 weeks · QA Director
  • Audit facility against EU GMP / FDA 21 CFR 211 / WHO-GMP; remediate gaps before pre-shipment inspection
  • Validate analytical methods per ICH Q2 / equivalent for Pharma
  • Stability data 3 commercial batches under ICH Q1A long-term + accelerated conditions
  • Document control system aligned with EU GMP Annex 11 / FDA Part 11 expectations
3 Buyer + commercial pre-qualification 2-6 weeks · Sales Director
  • Issue NDA + ' . UAE . ' KYC pack to ' . UAE . ' buyer; receive corporate registration + VAT/EORI evidence
  • Negotiate Incoterm + payment terms; align on LC/D-P/Open-account based on relationship maturity
  • Procure ECGC Standard Policy at 0.15-0.30% premium for new UAE buyer exposure
  • Lock currency + price-validity per quarterly hedging policy
4 Production + pre-shipment inspection 4-24 weeks · Operations
  • Production per validated MBR; release per QA SOPs; CoA per batch in EU 10204 3.1 format
  • Pre-shipment inspection by Bureau Veritas / SGS / Intertek per UAE import-permit requirement
  • Container stuffing supervised + sealed; container photos + weighbridge slip captured
  • CBAM embedded-emissions data computed if applicable per EU Regulation 2023/956
5 Export documentation + customs clearance 3-7 days · Export Documentation
  • Commercial invoice + packing list + COO from PHARMEXCIL/EEPC/AEPC/etc
  • Shipping bill + RoDTEP claim + DBK claim filed on ICEGATE
  • B/L draft amended + final telex release; copies released against payment per LC terms
  • CIF/DAP marine cargo insurance ICC(A) for full invoice value + 10%
6 Post-shipment + working capital recovery 30-180 days · Finance + QA
  • Bank realisation certificate (BRC) within 9 months of shipment per FEMA
  • Apply RoDTEP 1.5% + DBK Schedule II band; FTA preference verification through TARIC; CBAM exposure assessed for relevant chapters
  • GST refund on accumulated ITC filed quarterly via RFD-01
  • Buyer feedback + claims review; corrective action for any quality / paperwork issue within 30 days

Key Documents

  • IEC
  • RCMC
  • Commercial Invoice
  • Packing List
  • Certificate of Origin
  • Bill of Lading
  • Marine Cargo Insurance Certificate
  • EU GMP / FDA 21 CFR 211 / WHO-GMP Certificate
  • CoA
  • Shipping Bill
  • BRC

Key Certifications

  • EU GMP / FDA 21 CFR 211 / WHO-GMP
  • ISO 9001:2015
  • ISO 14001:2015
  • SA8000

Common Mistakes

  • Assuming Indian quality standards equal UAE regulatory expectations — always engage local consultant
  • Missing CBAM transitional reports for relevant HS chapters — quarterly filing now mandatory
  • Insufficient pre-shipment inspection — recovery cost on UAE QC rejection is 4-7x avoidance cost
  • RoDTEP filing forgetfulness — 1.5-4% margin literally lost forever after the 60-day window

AJG Tools for This Vertical

AJG FTA Savings Estimator — calculates duty saving on the relevant FTA preference AJG Pharma Compliance Pack — pre-built evidence file aligned to EU GMP / FDA 21 CFR 211 / WHO-GMP AJG UAE Buyer Pre-qualification — KYC + reference checks
Submit Pharma Mandate →
Pharma v1.0 · 2026-04-27

Pharma export SOP — India to Taiwan

End-to-end pathway for Pharma exports from India to Taiwan. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, expor...

6 steps
↓ Expand

End-to-end pathway for Pharma exports from India to Taiwan. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, export documentation (commercial invoice, packing list, certificate of origin, B/L, insurance certificate), Incoterm-aligned pricing, payment mechanics, lead-time management, and post-shipment compliance for the Taiwan regime.

Prerequisites

  • IEC issued by DGFT for the manufacturing entity
  • RCMC from the relevant Export Promotion Council for Pharma
  • EU GMP / FDA 21 CFR 211 / WHO-GMP compliance evidence package
  • Taiwan importer pre-qualification + freight forwarder appointment
  • ECGC Standard Policy or equivalent receivables cover for new buyer
  • LUT bond filed on GSTN for zero-rated GST on the export

Step-by-Step Process

1 Regulatory pathway selection 3-8 weeks · Regulatory Affairs
  • Confirm HS classification across CN8 / TARIC for Pharma consignment
  • Map Taiwan import regime: MFN duty, GSP eligibility, FTA preference, anti-dumping/CVD exposure
  • Identify EU GMP / FDA 21 CFR 211 / WHO-GMP as primary regulatory stack; build evidence dossier 90 days ahead of first shipment
  • Engage local Taiwan regulatory consultant if novel-substance or MA-type filings are required
2 Manufacturing readiness 4-16 weeks · QA Director
  • Audit facility against EU GMP / FDA 21 CFR 211 / WHO-GMP; remediate gaps before pre-shipment inspection
  • Validate analytical methods per ICH Q2 / equivalent for Pharma
  • Stability data 3 commercial batches under ICH Q1A long-term + accelerated conditions
  • Document control system aligned with EU GMP Annex 11 / FDA Part 11 expectations
3 Buyer + commercial pre-qualification 2-6 weeks · Sales Director
  • Issue NDA + ' . Taiwan . ' KYC pack to ' . Taiwan . ' buyer; receive corporate registration + VAT/EORI evidence
  • Negotiate Incoterm + payment terms; align on LC/D-P/Open-account based on relationship maturity
  • Procure ECGC Standard Policy at 0.15-0.30% premium for new Taiwan buyer exposure
  • Lock currency + price-validity per quarterly hedging policy
4 Production + pre-shipment inspection 4-24 weeks · Operations
  • Production per validated MBR; release per QA SOPs; CoA per batch in EU 10204 3.1 format
  • Pre-shipment inspection by Bureau Veritas / SGS / Intertek per Taiwan import-permit requirement
  • Container stuffing supervised + sealed; container photos + weighbridge slip captured
  • CBAM embedded-emissions data computed if applicable per EU Regulation 2023/956
5 Export documentation + customs clearance 3-7 days · Export Documentation
  • Commercial invoice + packing list + COO from PHARMEXCIL/EEPC/AEPC/etc
  • Shipping bill + RoDTEP claim + DBK claim filed on ICEGATE
  • B/L draft amended + final telex release; copies released against payment per LC terms
  • CIF/DAP marine cargo insurance ICC(A) for full invoice value + 10%
6 Post-shipment + working capital recovery 30-180 days · Finance + QA
  • Bank realisation certificate (BRC) within 9 months of shipment per FEMA
  • Apply RoDTEP 1.5% + DBK Schedule II band; FTA preference verification through TARIC; CBAM exposure assessed for relevant chapters
  • GST refund on accumulated ITC filed quarterly via RFD-01
  • Buyer feedback + claims review; corrective action for any quality / paperwork issue within 30 days

Key Documents

  • IEC
  • RCMC
  • Commercial Invoice
  • Packing List
  • Certificate of Origin
  • Bill of Lading
  • Marine Cargo Insurance Certificate
  • EU GMP / FDA 21 CFR 211 / WHO-GMP Certificate
  • CoA
  • Shipping Bill
  • BRC

Key Certifications

  • EU GMP / FDA 21 CFR 211 / WHO-GMP
  • ISO 9001:2015
  • ISO 14001:2015
  • SA8000

Common Mistakes

  • Assuming Indian quality standards equal Taiwan regulatory expectations — always engage local consultant
  • Missing CBAM transitional reports for relevant HS chapters — quarterly filing now mandatory
  • Insufficient pre-shipment inspection — recovery cost on Taiwan QC rejection is 4-7x avoidance cost
  • RoDTEP filing forgetfulness — 1.5-4% margin literally lost forever after the 60-day window

AJG Tools for This Vertical

AJG FTA Savings Estimator — calculates duty saving on the relevant FTA preference AJG Pharma Compliance Pack — pre-built evidence file aligned to EU GMP / FDA 21 CFR 211 / WHO-GMP AJG Taiwan Buyer Pre-qualification — KYC + reference checks
Submit Pharma Mandate →
Pharma v1.0 · 2026-04-27

Pharma export SOP — India to Argentina

End-to-end pathway for Pharma exports from India to Argentina. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, ex...

6 steps
↓ Expand

End-to-end pathway for Pharma exports from India to Argentina. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, export documentation (commercial invoice, packing list, certificate of origin, B/L, insurance certificate), Incoterm-aligned pricing, payment mechanics, lead-time management, and post-shipment compliance for the Argentina regime.

Prerequisites

  • IEC issued by DGFT for the manufacturing entity
  • RCMC from the relevant Export Promotion Council for Pharma
  • EU GMP / FDA 21 CFR 211 / WHO-GMP compliance evidence package
  • Argentina importer pre-qualification + freight forwarder appointment
  • ECGC Standard Policy or equivalent receivables cover for new buyer
  • LUT bond filed on GSTN for zero-rated GST on the export

Step-by-Step Process

1 Regulatory pathway selection 3-8 weeks · Regulatory Affairs
  • Confirm HS classification across CN8 / TARIC for Pharma consignment
  • Map Argentina import regime: MFN duty, GSP eligibility, FTA preference, anti-dumping/CVD exposure
  • Identify EU GMP / FDA 21 CFR 211 / WHO-GMP as primary regulatory stack; build evidence dossier 90 days ahead of first shipment
  • Engage local Argentina regulatory consultant if novel-substance or MA-type filings are required
2 Manufacturing readiness 4-16 weeks · QA Director
  • Audit facility against EU GMP / FDA 21 CFR 211 / WHO-GMP; remediate gaps before pre-shipment inspection
  • Validate analytical methods per ICH Q2 / equivalent for Pharma
  • Stability data 3 commercial batches under ICH Q1A long-term + accelerated conditions
  • Document control system aligned with EU GMP Annex 11 / FDA Part 11 expectations
3 Buyer + commercial pre-qualification 2-6 weeks · Sales Director
  • Issue NDA + ' . Argentina . ' KYC pack to ' . Argentina . ' buyer; receive corporate registration + VAT/EORI evidence
  • Negotiate Incoterm + payment terms; align on LC/D-P/Open-account based on relationship maturity
  • Procure ECGC Standard Policy at 0.15-0.30% premium for new Argentina buyer exposure
  • Lock currency + price-validity per quarterly hedging policy
4 Production + pre-shipment inspection 4-24 weeks · Operations
  • Production per validated MBR; release per QA SOPs; CoA per batch in EU 10204 3.1 format
  • Pre-shipment inspection by Bureau Veritas / SGS / Intertek per Argentina import-permit requirement
  • Container stuffing supervised + sealed; container photos + weighbridge slip captured
  • CBAM embedded-emissions data computed if applicable per EU Regulation 2023/956
5 Export documentation + customs clearance 3-7 days · Export Documentation
  • Commercial invoice + packing list + COO from PHARMEXCIL/EEPC/AEPC/etc
  • Shipping bill + RoDTEP claim + DBK claim filed on ICEGATE
  • B/L draft amended + final telex release; copies released against payment per LC terms
  • CIF/DAP marine cargo insurance ICC(A) for full invoice value + 10%
6 Post-shipment + working capital recovery 30-180 days · Finance + QA
  • Bank realisation certificate (BRC) within 9 months of shipment per FEMA
  • Apply RoDTEP 3.9% + DBK Schedule II band; FTA preference verification through TARIC; CBAM exposure assessed for relevant chapters
  • GST refund on accumulated ITC filed quarterly via RFD-01
  • Buyer feedback + claims review; corrective action for any quality / paperwork issue within 30 days

Key Documents

  • IEC
  • RCMC
  • Commercial Invoice
  • Packing List
  • Certificate of Origin
  • Bill of Lading
  • Marine Cargo Insurance Certificate
  • EU GMP / FDA 21 CFR 211 / WHO-GMP Certificate
  • CoA
  • Shipping Bill
  • BRC

Key Certifications

  • EU GMP / FDA 21 CFR 211 / WHO-GMP
  • ISO 9001:2015
  • ISO 14001:2015
  • SA8000

Common Mistakes

  • Assuming Indian quality standards equal Argentina regulatory expectations — always engage local consultant
  • Missing CBAM transitional reports for relevant HS chapters — quarterly filing now mandatory
  • Insufficient pre-shipment inspection — recovery cost on Argentina QC rejection is 4-7x avoidance cost
  • RoDTEP filing forgetfulness — 1.5-4% margin literally lost forever after the 60-day window

AJG Tools for This Vertical

AJG FTA Savings Estimator — calculates duty saving on the relevant FTA preference AJG Pharma Compliance Pack — pre-built evidence file aligned to EU GMP / FDA 21 CFR 211 / WHO-GMP AJG Argentina Buyer Pre-qualification — KYC + reference checks
Submit Pharma Mandate →
Pharma v1.0 · 2026-04-27

Pharma export SOP — India to New Zealand

End-to-end pathway for Pharma exports from India to New Zealand. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, ...

6 steps
↓ Expand

End-to-end pathway for Pharma exports from India to New Zealand. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, export documentation (commercial invoice, packing list, certificate of origin, B/L, insurance certificate), Incoterm-aligned pricing, payment mechanics, lead-time management, and post-shipment compliance for the New Zealand regime.

Prerequisites

  • IEC issued by DGFT for the manufacturing entity
  • RCMC from the relevant Export Promotion Council for Pharma
  • EU GMP / FDA 21 CFR 211 / WHO-GMP compliance evidence package
  • New Zealand importer pre-qualification + freight forwarder appointment
  • ECGC Standard Policy or equivalent receivables cover for new buyer
  • LUT bond filed on GSTN for zero-rated GST on the export

Step-by-Step Process

1 Regulatory pathway selection 3-8 weeks · Regulatory Affairs
  • Confirm HS classification across CN8 / TARIC for Pharma consignment
  • Map New Zealand import regime: MFN duty, GSP eligibility, FTA preference, anti-dumping/CVD exposure
  • Identify EU GMP / FDA 21 CFR 211 / WHO-GMP as primary regulatory stack; build evidence dossier 90 days ahead of first shipment
  • Engage local New Zealand regulatory consultant if novel-substance or MA-type filings are required
2 Manufacturing readiness 4-16 weeks · QA Director
  • Audit facility against EU GMP / FDA 21 CFR 211 / WHO-GMP; remediate gaps before pre-shipment inspection
  • Validate analytical methods per ICH Q2 / equivalent for Pharma
  • Stability data 3 commercial batches under ICH Q1A long-term + accelerated conditions
  • Document control system aligned with EU GMP Annex 11 / FDA Part 11 expectations
3 Buyer + commercial pre-qualification 2-6 weeks · Sales Director
  • Issue NDA + ' . New Zealand . ' KYC pack to ' . New Zealand . ' buyer; receive corporate registration + VAT/EORI evidence
  • Negotiate Incoterm + payment terms; align on LC/D-P/Open-account based on relationship maturity
  • Procure ECGC Standard Policy at 0.15-0.30% premium for new New Zealand buyer exposure
  • Lock currency + price-validity per quarterly hedging policy
4 Production + pre-shipment inspection 4-24 weeks · Operations
  • Production per validated MBR; release per QA SOPs; CoA per batch in EU 10204 3.1 format
  • Pre-shipment inspection by Bureau Veritas / SGS / Intertek per New Zealand import-permit requirement
  • Container stuffing supervised + sealed; container photos + weighbridge slip captured
  • CBAM embedded-emissions data computed if applicable per EU Regulation 2023/956
5 Export documentation + customs clearance 3-7 days · Export Documentation
  • Commercial invoice + packing list + COO from PHARMEXCIL/EEPC/AEPC/etc
  • Shipping bill + RoDTEP claim + DBK claim filed on ICEGATE
  • B/L draft amended + final telex release; copies released against payment per LC terms
  • CIF/DAP marine cargo insurance ICC(A) for full invoice value + 10%
6 Post-shipment + working capital recovery 30-180 days · Finance + QA
  • Bank realisation certificate (BRC) within 9 months of shipment per FEMA
  • Apply RoDTEP 2.3% + DBK Schedule II band; FTA preference verification through TARIC; CBAM exposure assessed for relevant chapters
  • GST refund on accumulated ITC filed quarterly via RFD-01
  • Buyer feedback + claims review; corrective action for any quality / paperwork issue within 30 days

Key Documents

  • IEC
  • RCMC
  • Commercial Invoice
  • Packing List
  • Certificate of Origin
  • Bill of Lading
  • Marine Cargo Insurance Certificate
  • EU GMP / FDA 21 CFR 211 / WHO-GMP Certificate
  • CoA
  • Shipping Bill
  • BRC

Key Certifications

  • EU GMP / FDA 21 CFR 211 / WHO-GMP
  • ISO 9001:2015
  • ISO 14001:2015
  • SA8000

Common Mistakes

  • Assuming Indian quality standards equal New Zealand regulatory expectations — always engage local consultant
  • Missing CBAM transitional reports for relevant HS chapters — quarterly filing now mandatory
  • Insufficient pre-shipment inspection — recovery cost on New Zealand QC rejection is 4-7x avoidance cost
  • RoDTEP filing forgetfulness — 1.5-4% margin literally lost forever after the 60-day window

AJG Tools for This Vertical

AJG FTA Savings Estimator — calculates duty saving on the relevant FTA preference AJG Pharma Compliance Pack — pre-built evidence file aligned to EU GMP / FDA 21 CFR 211 / WHO-GMP AJG New Zealand Buyer Pre-qualification — KYC + reference checks
Submit Pharma Mandate →
Pharma v1.0 · 2026-04-27

Pharma export SOP — India to Canada

End-to-end pathway for Pharma exports from India to Canada. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, expor...

6 steps
↓ Expand

End-to-end pathway for Pharma exports from India to Canada. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, export documentation (commercial invoice, packing list, certificate of origin, B/L, insurance certificate), Incoterm-aligned pricing, payment mechanics, lead-time management, and post-shipment compliance for the Canada regime.

Prerequisites

  • IEC issued by DGFT for the manufacturing entity
  • RCMC from the relevant Export Promotion Council for Pharma
  • EU GMP / FDA 21 CFR 211 / WHO-GMP compliance evidence package
  • Canada importer pre-qualification + freight forwarder appointment
  • ECGC Standard Policy or equivalent receivables cover for new buyer
  • LUT bond filed on GSTN for zero-rated GST on the export

Step-by-Step Process

1 Regulatory pathway selection 3-8 weeks · Regulatory Affairs
  • Confirm HS classification across CN8 / TARIC for Pharma consignment
  • Map Canada import regime: MFN duty, GSP eligibility, FTA preference, anti-dumping/CVD exposure
  • Identify EU GMP / FDA 21 CFR 211 / WHO-GMP as primary regulatory stack; build evidence dossier 90 days ahead of first shipment
  • Engage local Canada regulatory consultant if novel-substance or MA-type filings are required
2 Manufacturing readiness 4-16 weeks · QA Director
  • Audit facility against EU GMP / FDA 21 CFR 211 / WHO-GMP; remediate gaps before pre-shipment inspection
  • Validate analytical methods per ICH Q2 / equivalent for Pharma
  • Stability data 3 commercial batches under ICH Q1A long-term + accelerated conditions
  • Document control system aligned with EU GMP Annex 11 / FDA Part 11 expectations
3 Buyer + commercial pre-qualification 2-6 weeks · Sales Director
  • Issue NDA + ' . Canada . ' KYC pack to ' . Canada . ' buyer; receive corporate registration + VAT/EORI evidence
  • Negotiate Incoterm + payment terms; align on LC/D-P/Open-account based on relationship maturity
  • Procure ECGC Standard Policy at 0.15-0.30% premium for new Canada buyer exposure
  • Lock currency + price-validity per quarterly hedging policy
4 Production + pre-shipment inspection 4-24 weeks · Operations
  • Production per validated MBR; release per QA SOPs; CoA per batch in EU 10204 3.1 format
  • Pre-shipment inspection by Bureau Veritas / SGS / Intertek per Canada import-permit requirement
  • Container stuffing supervised + sealed; container photos + weighbridge slip captured
  • CBAM embedded-emissions data computed if applicable per EU Regulation 2023/956
5 Export documentation + customs clearance 3-7 days · Export Documentation
  • Commercial invoice + packing list + COO from PHARMEXCIL/EEPC/AEPC/etc
  • Shipping bill + RoDTEP claim + DBK claim filed on ICEGATE
  • B/L draft amended + final telex release; copies released against payment per LC terms
  • CIF/DAP marine cargo insurance ICC(A) for full invoice value + 10%
6 Post-shipment + working capital recovery 30-180 days · Finance + QA
  • Bank realisation certificate (BRC) within 9 months of shipment per FEMA
  • Apply RoDTEP 1.5% + DBK Schedule II band; FTA preference verification through TARIC; CBAM exposure assessed for relevant chapters
  • GST refund on accumulated ITC filed quarterly via RFD-01
  • Buyer feedback + claims review; corrective action for any quality / paperwork issue within 30 days

Key Documents

  • IEC
  • RCMC
  • Commercial Invoice
  • Packing List
  • Certificate of Origin
  • Bill of Lading
  • Marine Cargo Insurance Certificate
  • EU GMP / FDA 21 CFR 211 / WHO-GMP Certificate
  • CoA
  • Shipping Bill
  • BRC

Key Certifications

  • EU GMP / FDA 21 CFR 211 / WHO-GMP
  • ISO 9001:2015
  • ISO 14001:2015
  • SA8000

Common Mistakes

  • Assuming Indian quality standards equal Canada regulatory expectations — always engage local consultant
  • Missing CBAM transitional reports for relevant HS chapters — quarterly filing now mandatory
  • Insufficient pre-shipment inspection — recovery cost on Canada QC rejection is 4-7x avoidance cost
  • RoDTEP filing forgetfulness — 1.5-4% margin literally lost forever after the 60-day window

AJG Tools for This Vertical

AJG FTA Savings Estimator — calculates duty saving on the relevant FTA preference AJG Pharma Compliance Pack — pre-built evidence file aligned to EU GMP / FDA 21 CFR 211 / WHO-GMP AJG Canada Buyer Pre-qualification — KYC + reference checks
Submit Pharma Mandate →
Pharma v1.0 · 2026-04-27

Pharma export SOP — India to Brazil

End-to-end pathway for Pharma exports from India to Brazil. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, expor...

6 steps
↓ Expand

End-to-end pathway for Pharma exports from India to Brazil. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, export documentation (commercial invoice, packing list, certificate of origin, B/L, insurance certificate), Incoterm-aligned pricing, payment mechanics, lead-time management, and post-shipment compliance for the Brazil regime.

Prerequisites

  • IEC issued by DGFT for the manufacturing entity
  • RCMC from the relevant Export Promotion Council for Pharma
  • EU GMP / FDA 21 CFR 211 / WHO-GMP compliance evidence package
  • Brazil importer pre-qualification + freight forwarder appointment
  • ECGC Standard Policy or equivalent receivables cover for new buyer
  • LUT bond filed on GSTN for zero-rated GST on the export

Step-by-Step Process

1 Regulatory pathway selection 3-8 weeks · Regulatory Affairs
  • Confirm HS classification across CN8 / TARIC for Pharma consignment
  • Map Brazil import regime: MFN duty, GSP eligibility, FTA preference, anti-dumping/CVD exposure
  • Identify EU GMP / FDA 21 CFR 211 / WHO-GMP as primary regulatory stack; build evidence dossier 90 days ahead of first shipment
  • Engage local Brazil regulatory consultant if novel-substance or MA-type filings are required
2 Manufacturing readiness 4-16 weeks · QA Director
  • Audit facility against EU GMP / FDA 21 CFR 211 / WHO-GMP; remediate gaps before pre-shipment inspection
  • Validate analytical methods per ICH Q2 / equivalent for Pharma
  • Stability data 3 commercial batches under ICH Q1A long-term + accelerated conditions
  • Document control system aligned with EU GMP Annex 11 / FDA Part 11 expectations
3 Buyer + commercial pre-qualification 2-6 weeks · Sales Director
  • Issue NDA + ' . Brazil . ' KYC pack to ' . Brazil . ' buyer; receive corporate registration + VAT/EORI evidence
  • Negotiate Incoterm + payment terms; align on LC/D-P/Open-account based on relationship maturity
  • Procure ECGC Standard Policy at 0.15-0.30% premium for new Brazil buyer exposure
  • Lock currency + price-validity per quarterly hedging policy
4 Production + pre-shipment inspection 4-24 weeks · Operations
  • Production per validated MBR; release per QA SOPs; CoA per batch in EU 10204 3.1 format
  • Pre-shipment inspection by Bureau Veritas / SGS / Intertek per Brazil import-permit requirement
  • Container stuffing supervised + sealed; container photos + weighbridge slip captured
  • CBAM embedded-emissions data computed if applicable per EU Regulation 2023/956
5 Export documentation + customs clearance 3-7 days · Export Documentation
  • Commercial invoice + packing list + COO from PHARMEXCIL/EEPC/AEPC/etc
  • Shipping bill + RoDTEP claim + DBK claim filed on ICEGATE
  • B/L draft amended + final telex release; copies released against payment per LC terms
  • CIF/DAP marine cargo insurance ICC(A) for full invoice value + 10%
6 Post-shipment + working capital recovery 30-180 days · Finance + QA
  • Bank realisation certificate (BRC) within 9 months of shipment per FEMA
  • Apply RoDTEP 2.3% + DBK Schedule II band; FTA preference verification through TARIC; CBAM exposure assessed for relevant chapters
  • GST refund on accumulated ITC filed quarterly via RFD-01
  • Buyer feedback + claims review; corrective action for any quality / paperwork issue within 30 days

Key Documents

  • IEC
  • RCMC
  • Commercial Invoice
  • Packing List
  • Certificate of Origin
  • Bill of Lading
  • Marine Cargo Insurance Certificate
  • EU GMP / FDA 21 CFR 211 / WHO-GMP Certificate
  • CoA
  • Shipping Bill
  • BRC

Key Certifications

  • EU GMP / FDA 21 CFR 211 / WHO-GMP
  • ISO 9001:2015
  • ISO 14001:2015
  • SA8000

Common Mistakes

  • Assuming Indian quality standards equal Brazil regulatory expectations — always engage local consultant
  • Missing CBAM transitional reports for relevant HS chapters — quarterly filing now mandatory
  • Insufficient pre-shipment inspection — recovery cost on Brazil QC rejection is 4-7x avoidance cost
  • RoDTEP filing forgetfulness — 1.5-4% margin literally lost forever after the 60-day window

AJG Tools for This Vertical

AJG FTA Savings Estimator — calculates duty saving on the relevant FTA preference AJG Pharma Compliance Pack — pre-built evidence file aligned to EU GMP / FDA 21 CFR 211 / WHO-GMP AJG Brazil Buyer Pre-qualification — KYC + reference checks
Submit Pharma Mandate →
Pharma v1.0 · 2026-04-27

Pharma export SOP — India to Philippines

End-to-end pathway for Pharma exports from India to Philippines. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, ...

6 steps
↓ Expand

End-to-end pathway for Pharma exports from India to Philippines. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, export documentation (commercial invoice, packing list, certificate of origin, B/L, insurance certificate), Incoterm-aligned pricing, payment mechanics, lead-time management, and post-shipment compliance for the Philippines regime.

Prerequisites

  • IEC issued by DGFT for the manufacturing entity
  • RCMC from the relevant Export Promotion Council for Pharma
  • EU GMP / FDA 21 CFR 211 / WHO-GMP compliance evidence package
  • Philippines importer pre-qualification + freight forwarder appointment
  • ECGC Standard Policy or equivalent receivables cover for new buyer
  • LUT bond filed on GSTN for zero-rated GST on the export

Step-by-Step Process

1 Regulatory pathway selection 3-8 weeks · Regulatory Affairs
  • Confirm HS classification across CN8 / TARIC for Pharma consignment
  • Map Philippines import regime: MFN duty, GSP eligibility, FTA preference, anti-dumping/CVD exposure
  • Identify EU GMP / FDA 21 CFR 211 / WHO-GMP as primary regulatory stack; build evidence dossier 90 days ahead of first shipment
  • Engage local Philippines regulatory consultant if novel-substance or MA-type filings are required
2 Manufacturing readiness 4-16 weeks · QA Director
  • Audit facility against EU GMP / FDA 21 CFR 211 / WHO-GMP; remediate gaps before pre-shipment inspection
  • Validate analytical methods per ICH Q2 / equivalent for Pharma
  • Stability data 3 commercial batches under ICH Q1A long-term + accelerated conditions
  • Document control system aligned with EU GMP Annex 11 / FDA Part 11 expectations
3 Buyer + commercial pre-qualification 2-6 weeks · Sales Director
  • Issue NDA + ' . Philippines . ' KYC pack to ' . Philippines . ' buyer; receive corporate registration + VAT/EORI evidence
  • Negotiate Incoterm + payment terms; align on LC/D-P/Open-account based on relationship maturity
  • Procure ECGC Standard Policy at 0.15-0.30% premium for new Philippines buyer exposure
  • Lock currency + price-validity per quarterly hedging policy
4 Production + pre-shipment inspection 4-24 weeks · Operations
  • Production per validated MBR; release per QA SOPs; CoA per batch in EU 10204 3.1 format
  • Pre-shipment inspection by Bureau Veritas / SGS / Intertek per Philippines import-permit requirement
  • Container stuffing supervised + sealed; container photos + weighbridge slip captured
  • CBAM embedded-emissions data computed if applicable per EU Regulation 2023/956
5 Export documentation + customs clearance 3-7 days · Export Documentation
  • Commercial invoice + packing list + COO from PHARMEXCIL/EEPC/AEPC/etc
  • Shipping bill + RoDTEP claim + DBK claim filed on ICEGATE
  • B/L draft amended + final telex release; copies released against payment per LC terms
  • CIF/DAP marine cargo insurance ICC(A) for full invoice value + 10%
6 Post-shipment + working capital recovery 30-180 days · Finance + QA
  • Bank realisation certificate (BRC) within 9 months of shipment per FEMA
  • Apply RoDTEP 3.9% + DBK Schedule II band; FTA preference verification through TARIC; CBAM exposure assessed for relevant chapters
  • GST refund on accumulated ITC filed quarterly via RFD-01
  • Buyer feedback + claims review; corrective action for any quality / paperwork issue within 30 days

Key Documents

  • IEC
  • RCMC
  • Commercial Invoice
  • Packing List
  • Certificate of Origin
  • Bill of Lading
  • Marine Cargo Insurance Certificate
  • EU GMP / FDA 21 CFR 211 / WHO-GMP Certificate
  • CoA
  • Shipping Bill
  • BRC

Key Certifications

  • EU GMP / FDA 21 CFR 211 / WHO-GMP
  • ISO 9001:2015
  • ISO 14001:2015
  • SA8000

Common Mistakes

  • Assuming Indian quality standards equal Philippines regulatory expectations — always engage local consultant
  • Missing CBAM transitional reports for relevant HS chapters — quarterly filing now mandatory
  • Insufficient pre-shipment inspection — recovery cost on Philippines QC rejection is 4-7x avoidance cost
  • RoDTEP filing forgetfulness — 1.5-4% margin literally lost forever after the 60-day window

AJG Tools for This Vertical

AJG FTA Savings Estimator — calculates duty saving on the relevant FTA preference AJG Pharma Compliance Pack — pre-built evidence file aligned to EU GMP / FDA 21 CFR 211 / WHO-GMP AJG Philippines Buyer Pre-qualification — KYC + reference checks
Submit Pharma Mandate →
Pharma v1.0 · 2026-04-27

Pharma export SOP — India to Malaysia

End-to-end pathway for Pharma exports from India to Malaysia. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, exp...

6 steps
↓ Expand

End-to-end pathway for Pharma exports from India to Malaysia. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, export documentation (commercial invoice, packing list, certificate of origin, B/L, insurance certificate), Incoterm-aligned pricing, payment mechanics, lead-time management, and post-shipment compliance for the Malaysia regime.

Prerequisites

  • IEC issued by DGFT for the manufacturing entity
  • RCMC from the relevant Export Promotion Council for Pharma
  • EU GMP / FDA 21 CFR 211 / WHO-GMP compliance evidence package
  • Malaysia importer pre-qualification + freight forwarder appointment
  • ECGC Standard Policy or equivalent receivables cover for new buyer
  • LUT bond filed on GSTN for zero-rated GST on the export

Step-by-Step Process

1 Regulatory pathway selection 3-8 weeks · Regulatory Affairs
  • Confirm HS classification across CN8 / TARIC for Pharma consignment
  • Map Malaysia import regime: MFN duty, GSP eligibility, FTA preference, anti-dumping/CVD exposure
  • Identify EU GMP / FDA 21 CFR 211 / WHO-GMP as primary regulatory stack; build evidence dossier 90 days ahead of first shipment
  • Engage local Malaysia regulatory consultant if novel-substance or MA-type filings are required
2 Manufacturing readiness 4-16 weeks · QA Director
  • Audit facility against EU GMP / FDA 21 CFR 211 / WHO-GMP; remediate gaps before pre-shipment inspection
  • Validate analytical methods per ICH Q2 / equivalent for Pharma
  • Stability data 3 commercial batches under ICH Q1A long-term + accelerated conditions
  • Document control system aligned with EU GMP Annex 11 / FDA Part 11 expectations
3 Buyer + commercial pre-qualification 2-6 weeks · Sales Director
  • Issue NDA + ' . Malaysia . ' KYC pack to ' . Malaysia . ' buyer; receive corporate registration + VAT/EORI evidence
  • Negotiate Incoterm + payment terms; align on LC/D-P/Open-account based on relationship maturity
  • Procure ECGC Standard Policy at 0.15-0.30% premium for new Malaysia buyer exposure
  • Lock currency + price-validity per quarterly hedging policy
4 Production + pre-shipment inspection 4-24 weeks · Operations
  • Production per validated MBR; release per QA SOPs; CoA per batch in EU 10204 3.1 format
  • Pre-shipment inspection by Bureau Veritas / SGS / Intertek per Malaysia import-permit requirement
  • Container stuffing supervised + sealed; container photos + weighbridge slip captured
  • CBAM embedded-emissions data computed if applicable per EU Regulation 2023/956
5 Export documentation + customs clearance 3-7 days · Export Documentation
  • Commercial invoice + packing list + COO from PHARMEXCIL/EEPC/AEPC/etc
  • Shipping bill + RoDTEP claim + DBK claim filed on ICEGATE
  • B/L draft amended + final telex release; copies released against payment per LC terms
  • CIF/DAP marine cargo insurance ICC(A) for full invoice value + 10%
6 Post-shipment + working capital recovery 30-180 days · Finance + QA
  • Bank realisation certificate (BRC) within 9 months of shipment per FEMA
  • Apply RoDTEP 3.1% + DBK Schedule II band; FTA preference verification through TARIC; CBAM exposure assessed for relevant chapters
  • GST refund on accumulated ITC filed quarterly via RFD-01
  • Buyer feedback + claims review; corrective action for any quality / paperwork issue within 30 days

Key Documents

  • IEC
  • RCMC
  • Commercial Invoice
  • Packing List
  • Certificate of Origin
  • Bill of Lading
  • Marine Cargo Insurance Certificate
  • EU GMP / FDA 21 CFR 211 / WHO-GMP Certificate
  • CoA
  • Shipping Bill
  • BRC

Key Certifications

  • EU GMP / FDA 21 CFR 211 / WHO-GMP
  • ISO 9001:2015
  • ISO 14001:2015
  • SA8000

Common Mistakes

  • Assuming Indian quality standards equal Malaysia regulatory expectations — always engage local consultant
  • Missing CBAM transitional reports for relevant HS chapters — quarterly filing now mandatory
  • Insufficient pre-shipment inspection — recovery cost on Malaysia QC rejection is 4-7x avoidance cost
  • RoDTEP filing forgetfulness — 1.5-4% margin literally lost forever after the 60-day window

AJG Tools for This Vertical

AJG FTA Savings Estimator — calculates duty saving on the relevant FTA preference AJG Pharma Compliance Pack — pre-built evidence file aligned to EU GMP / FDA 21 CFR 211 / WHO-GMP AJG Malaysia Buyer Pre-qualification — KYC + reference checks
Submit Pharma Mandate →
Pharma v1.0 · 2026-04-27

Pharma export SOP — India to Chile

End-to-end pathway for Pharma exports from India to Chile. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, export...

6 steps
↓ Expand

End-to-end pathway for Pharma exports from India to Chile. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, export documentation (commercial invoice, packing list, certificate of origin, B/L, insurance certificate), Incoterm-aligned pricing, payment mechanics, lead-time management, and post-shipment compliance for the Chile regime.

Prerequisites

  • IEC issued by DGFT for the manufacturing entity
  • RCMC from the relevant Export Promotion Council for Pharma
  • EU GMP / FDA 21 CFR 211 / WHO-GMP compliance evidence package
  • Chile importer pre-qualification + freight forwarder appointment
  • ECGC Standard Policy or equivalent receivables cover for new buyer
  • LUT bond filed on GSTN for zero-rated GST on the export

Step-by-Step Process

1 Regulatory pathway selection 3-8 weeks · Regulatory Affairs
  • Confirm HS classification across CN8 / TARIC for Pharma consignment
  • Map Chile import regime: MFN duty, GSP eligibility, FTA preference, anti-dumping/CVD exposure
  • Identify EU GMP / FDA 21 CFR 211 / WHO-GMP as primary regulatory stack; build evidence dossier 90 days ahead of first shipment
  • Engage local Chile regulatory consultant if novel-substance or MA-type filings are required
2 Manufacturing readiness 4-16 weeks · QA Director
  • Audit facility against EU GMP / FDA 21 CFR 211 / WHO-GMP; remediate gaps before pre-shipment inspection
  • Validate analytical methods per ICH Q2 / equivalent for Pharma
  • Stability data 3 commercial batches under ICH Q1A long-term + accelerated conditions
  • Document control system aligned with EU GMP Annex 11 / FDA Part 11 expectations
3 Buyer + commercial pre-qualification 2-6 weeks · Sales Director
  • Issue NDA + ' . Chile . ' KYC pack to ' . Chile . ' buyer; receive corporate registration + VAT/EORI evidence
  • Negotiate Incoterm + payment terms; align on LC/D-P/Open-account based on relationship maturity
  • Procure ECGC Standard Policy at 0.15-0.30% premium for new Chile buyer exposure
  • Lock currency + price-validity per quarterly hedging policy
4 Production + pre-shipment inspection 4-24 weeks · Operations
  • Production per validated MBR; release per QA SOPs; CoA per batch in EU 10204 3.1 format
  • Pre-shipment inspection by Bureau Veritas / SGS / Intertek per Chile import-permit requirement
  • Container stuffing supervised + sealed; container photos + weighbridge slip captured
  • CBAM embedded-emissions data computed if applicable per EU Regulation 2023/956
5 Export documentation + customs clearance 3-7 days · Export Documentation
  • Commercial invoice + packing list + COO from PHARMEXCIL/EEPC/AEPC/etc
  • Shipping bill + RoDTEP claim + DBK claim filed on ICEGATE
  • B/L draft amended + final telex release; copies released against payment per LC terms
  • CIF/DAP marine cargo insurance ICC(A) for full invoice value + 10%
6 Post-shipment + working capital recovery 30-180 days · Finance + QA
  • Bank realisation certificate (BRC) within 9 months of shipment per FEMA
  • Apply RoDTEP 2.7% + DBK Schedule II band; FTA preference verification through TARIC; CBAM exposure assessed for relevant chapters
  • GST refund on accumulated ITC filed quarterly via RFD-01
  • Buyer feedback + claims review; corrective action for any quality / paperwork issue within 30 days

Key Documents

  • IEC
  • RCMC
  • Commercial Invoice
  • Packing List
  • Certificate of Origin
  • Bill of Lading
  • Marine Cargo Insurance Certificate
  • EU GMP / FDA 21 CFR 211 / WHO-GMP Certificate
  • CoA
  • Shipping Bill
  • BRC

Key Certifications

  • EU GMP / FDA 21 CFR 211 / WHO-GMP
  • ISO 9001:2015
  • ISO 14001:2015
  • SA8000

Common Mistakes

  • Assuming Indian quality standards equal Chile regulatory expectations — always engage local consultant
  • Missing CBAM transitional reports for relevant HS chapters — quarterly filing now mandatory
  • Insufficient pre-shipment inspection — recovery cost on Chile QC rejection is 4-7x avoidance cost
  • RoDTEP filing forgetfulness — 1.5-4% margin literally lost forever after the 60-day window

AJG Tools for This Vertical

AJG FTA Savings Estimator — calculates duty saving on the relevant FTA preference AJG Pharma Compliance Pack — pre-built evidence file aligned to EU GMP / FDA 21 CFR 211 / WHO-GMP AJG Chile Buyer Pre-qualification — KYC + reference checks
Submit Pharma Mandate →
Pharma v1.0 · 2026-04-27

Pharma export SOP — India to Vietnam

End-to-end pathway for Pharma exports from India to Vietnam. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, expo...

6 steps
↓ Expand

End-to-end pathway for Pharma exports from India to Vietnam. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, export documentation (commercial invoice, packing list, certificate of origin, B/L, insurance certificate), Incoterm-aligned pricing, payment mechanics, lead-time management, and post-shipment compliance for the Vietnam regime.

Prerequisites

  • IEC issued by DGFT for the manufacturing entity
  • RCMC from the relevant Export Promotion Council for Pharma
  • EU GMP / FDA 21 CFR 211 / WHO-GMP compliance evidence package
  • Vietnam importer pre-qualification + freight forwarder appointment
  • ECGC Standard Policy or equivalent receivables cover for new buyer
  • LUT bond filed on GSTN for zero-rated GST on the export

Step-by-Step Process

1 Regulatory pathway selection 3-8 weeks · Regulatory Affairs
  • Confirm HS classification across CN8 / TARIC for Pharma consignment
  • Map Vietnam import regime: MFN duty, GSP eligibility, FTA preference, anti-dumping/CVD exposure
  • Identify EU GMP / FDA 21 CFR 211 / WHO-GMP as primary regulatory stack; build evidence dossier 90 days ahead of first shipment
  • Engage local Vietnam regulatory consultant if novel-substance or MA-type filings are required
2 Manufacturing readiness 4-16 weeks · QA Director
  • Audit facility against EU GMP / FDA 21 CFR 211 / WHO-GMP; remediate gaps before pre-shipment inspection
  • Validate analytical methods per ICH Q2 / equivalent for Pharma
  • Stability data 3 commercial batches under ICH Q1A long-term + accelerated conditions
  • Document control system aligned with EU GMP Annex 11 / FDA Part 11 expectations
3 Buyer + commercial pre-qualification 2-6 weeks · Sales Director
  • Issue NDA + ' . Vietnam . ' KYC pack to ' . Vietnam . ' buyer; receive corporate registration + VAT/EORI evidence
  • Negotiate Incoterm + payment terms; align on LC/D-P/Open-account based on relationship maturity
  • Procure ECGC Standard Policy at 0.15-0.30% premium for new Vietnam buyer exposure
  • Lock currency + price-validity per quarterly hedging policy
4 Production + pre-shipment inspection 4-24 weeks · Operations
  • Production per validated MBR; release per QA SOPs; CoA per batch in EU 10204 3.1 format
  • Pre-shipment inspection by Bureau Veritas / SGS / Intertek per Vietnam import-permit requirement
  • Container stuffing supervised + sealed; container photos + weighbridge slip captured
  • CBAM embedded-emissions data computed if applicable per EU Regulation 2023/956
5 Export documentation + customs clearance 3-7 days · Export Documentation
  • Commercial invoice + packing list + COO from PHARMEXCIL/EEPC/AEPC/etc
  • Shipping bill + RoDTEP claim + DBK claim filed on ICEGATE
  • B/L draft amended + final telex release; copies released against payment per LC terms
  • CIF/DAP marine cargo insurance ICC(A) for full invoice value + 10%
6 Post-shipment + working capital recovery 30-180 days · Finance + QA
  • Bank realisation certificate (BRC) within 9 months of shipment per FEMA
  • Apply RoDTEP 2.7% + DBK Schedule II band; FTA preference verification through TARIC; CBAM exposure assessed for relevant chapters
  • GST refund on accumulated ITC filed quarterly via RFD-01
  • Buyer feedback + claims review; corrective action for any quality / paperwork issue within 30 days

Key Documents

  • IEC
  • RCMC
  • Commercial Invoice
  • Packing List
  • Certificate of Origin
  • Bill of Lading
  • Marine Cargo Insurance Certificate
  • EU GMP / FDA 21 CFR 211 / WHO-GMP Certificate
  • CoA
  • Shipping Bill
  • BRC

Key Certifications

  • EU GMP / FDA 21 CFR 211 / WHO-GMP
  • ISO 9001:2015
  • ISO 14001:2015
  • SA8000

Common Mistakes

  • Assuming Indian quality standards equal Vietnam regulatory expectations — always engage local consultant
  • Missing CBAM transitional reports for relevant HS chapters — quarterly filing now mandatory
  • Insufficient pre-shipment inspection — recovery cost on Vietnam QC rejection is 4-7x avoidance cost
  • RoDTEP filing forgetfulness — 1.5-4% margin literally lost forever after the 60-day window

AJG Tools for This Vertical

AJG FTA Savings Estimator — calculates duty saving on the relevant FTA preference AJG Pharma Compliance Pack — pre-built evidence file aligned to EU GMP / FDA 21 CFR 211 / WHO-GMP AJG Vietnam Buyer Pre-qualification — KYC + reference checks
Submit Pharma Mandate →
Pharma v1.0 · 2026-04-27

Pharma export SOP — India to Mexico

End-to-end pathway for Pharma exports from India to Mexico. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, expor...

6 steps
↓ Expand

End-to-end pathway for Pharma exports from India to Mexico. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, export documentation (commercial invoice, packing list, certificate of origin, B/L, insurance certificate), Incoterm-aligned pricing, payment mechanics, lead-time management, and post-shipment compliance for the Mexico regime.

Prerequisites

  • IEC issued by DGFT for the manufacturing entity
  • RCMC from the relevant Export Promotion Council for Pharma
  • EU GMP / FDA 21 CFR 211 / WHO-GMP compliance evidence package
  • Mexico importer pre-qualification + freight forwarder appointment
  • ECGC Standard Policy or equivalent receivables cover for new buyer
  • LUT bond filed on GSTN for zero-rated GST on the export

Step-by-Step Process

1 Regulatory pathway selection 3-8 weeks · Regulatory Affairs
  • Confirm HS classification across CN8 / TARIC for Pharma consignment
  • Map Mexico import regime: MFN duty, GSP eligibility, FTA preference, anti-dumping/CVD exposure
  • Identify EU GMP / FDA 21 CFR 211 / WHO-GMP as primary regulatory stack; build evidence dossier 90 days ahead of first shipment
  • Engage local Mexico regulatory consultant if novel-substance or MA-type filings are required
2 Manufacturing readiness 4-16 weeks · QA Director
  • Audit facility against EU GMP / FDA 21 CFR 211 / WHO-GMP; remediate gaps before pre-shipment inspection
  • Validate analytical methods per ICH Q2 / equivalent for Pharma
  • Stability data 3 commercial batches under ICH Q1A long-term + accelerated conditions
  • Document control system aligned with EU GMP Annex 11 / FDA Part 11 expectations
3 Buyer + commercial pre-qualification 2-6 weeks · Sales Director
  • Issue NDA + ' . Mexico . ' KYC pack to ' . Mexico . ' buyer; receive corporate registration + VAT/EORI evidence
  • Negotiate Incoterm + payment terms; align on LC/D-P/Open-account based on relationship maturity
  • Procure ECGC Standard Policy at 0.15-0.30% premium for new Mexico buyer exposure
  • Lock currency + price-validity per quarterly hedging policy
4 Production + pre-shipment inspection 4-24 weeks · Operations
  • Production per validated MBR; release per QA SOPs; CoA per batch in EU 10204 3.1 format
  • Pre-shipment inspection by Bureau Veritas / SGS / Intertek per Mexico import-permit requirement
  • Container stuffing supervised + sealed; container photos + weighbridge slip captured
  • CBAM embedded-emissions data computed if applicable per EU Regulation 2023/956
5 Export documentation + customs clearance 3-7 days · Export Documentation
  • Commercial invoice + packing list + COO from PHARMEXCIL/EEPC/AEPC/etc
  • Shipping bill + RoDTEP claim + DBK claim filed on ICEGATE
  • B/L draft amended + final telex release; copies released against payment per LC terms
  • CIF/DAP marine cargo insurance ICC(A) for full invoice value + 10%
6 Post-shipment + working capital recovery 30-180 days · Finance + QA
  • Bank realisation certificate (BRC) within 9 months of shipment per FEMA
  • Apply RoDTEP 3.9% + DBK Schedule II band; FTA preference verification through TARIC; CBAM exposure assessed for relevant chapters
  • GST refund on accumulated ITC filed quarterly via RFD-01
  • Buyer feedback + claims review; corrective action for any quality / paperwork issue within 30 days

Key Documents

  • IEC
  • RCMC
  • Commercial Invoice
  • Packing List
  • Certificate of Origin
  • Bill of Lading
  • Marine Cargo Insurance Certificate
  • EU GMP / FDA 21 CFR 211 / WHO-GMP Certificate
  • CoA
  • Shipping Bill
  • BRC

Key Certifications

  • EU GMP / FDA 21 CFR 211 / WHO-GMP
  • ISO 9001:2015
  • ISO 14001:2015
  • SA8000

Common Mistakes

  • Assuming Indian quality standards equal Mexico regulatory expectations — always engage local consultant
  • Missing CBAM transitional reports for relevant HS chapters — quarterly filing now mandatory
  • Insufficient pre-shipment inspection — recovery cost on Mexico QC rejection is 4-7x avoidance cost
  • RoDTEP filing forgetfulness — 1.5-4% margin literally lost forever after the 60-day window

AJG Tools for This Vertical

AJG FTA Savings Estimator — calculates duty saving on the relevant FTA preference AJG Pharma Compliance Pack — pre-built evidence file aligned to EU GMP / FDA 21 CFR 211 / WHO-GMP AJG Mexico Buyer Pre-qualification — KYC + reference checks
Submit Pharma Mandate →
Pharma v1.0 · 2026-04-27

Pharma export SOP — India to Italy

End-to-end pathway for Pharma exports from India to Italy. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, export...

6 steps
↓ Expand

End-to-end pathway for Pharma exports from India to Italy. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, export documentation (commercial invoice, packing list, certificate of origin, B/L, insurance certificate), Incoterm-aligned pricing, payment mechanics, lead-time management, and post-shipment compliance for the Italy regime.

Prerequisites

  • IEC issued by DGFT for the manufacturing entity
  • RCMC from the relevant Export Promotion Council for Pharma
  • EU GMP / FDA 21 CFR 211 / WHO-GMP compliance evidence package
  • Italy importer pre-qualification + freight forwarder appointment
  • ECGC Standard Policy or equivalent receivables cover for new buyer
  • LUT bond filed on GSTN for zero-rated GST on the export

Step-by-Step Process

1 Regulatory pathway selection 3-8 weeks · Regulatory Affairs
  • Confirm HS classification across CN8 / TARIC for Pharma consignment
  • Map Italy import regime: MFN duty, GSP eligibility, FTA preference, anti-dumping/CVD exposure
  • Identify EU GMP / FDA 21 CFR 211 / WHO-GMP as primary regulatory stack; build evidence dossier 90 days ahead of first shipment
  • Engage local Italy regulatory consultant if novel-substance or MA-type filings are required
2 Manufacturing readiness 4-16 weeks · QA Director
  • Audit facility against EU GMP / FDA 21 CFR 211 / WHO-GMP; remediate gaps before pre-shipment inspection
  • Validate analytical methods per ICH Q2 / equivalent for Pharma
  • Stability data 3 commercial batches under ICH Q1A long-term + accelerated conditions
  • Document control system aligned with EU GMP Annex 11 / FDA Part 11 expectations
3 Buyer + commercial pre-qualification 2-6 weeks · Sales Director
  • Issue NDA + ' . Italy . ' KYC pack to ' . Italy . ' buyer; receive corporate registration + VAT/EORI evidence
  • Negotiate Incoterm + payment terms; align on LC/D-P/Open-account based on relationship maturity
  • Procure ECGC Standard Policy at 0.15-0.30% premium for new Italy buyer exposure
  • Lock currency + price-validity per quarterly hedging policy
4 Production + pre-shipment inspection 4-24 weeks · Operations
  • Production per validated MBR; release per QA SOPs; CoA per batch in EU 10204 3.1 format
  • Pre-shipment inspection by Bureau Veritas / SGS / Intertek per Italy import-permit requirement
  • Container stuffing supervised + sealed; container photos + weighbridge slip captured
  • CBAM embedded-emissions data computed if applicable per EU Regulation 2023/956
5 Export documentation + customs clearance 3-7 days · Export Documentation
  • Commercial invoice + packing list + COO from PHARMEXCIL/EEPC/AEPC/etc
  • Shipping bill + RoDTEP claim + DBK claim filed on ICEGATE
  • B/L draft amended + final telex release; copies released against payment per LC terms
  • CIF/DAP marine cargo insurance ICC(A) for full invoice value + 10%
6 Post-shipment + working capital recovery 30-180 days · Finance + QA
  • Bank realisation certificate (BRC) within 9 months of shipment per FEMA
  • Apply RoDTEP 1.5% + DBK Schedule II band; FTA preference verification through TARIC; CBAM exposure assessed for relevant chapters
  • GST refund on accumulated ITC filed quarterly via RFD-01
  • Buyer feedback + claims review; corrective action for any quality / paperwork issue within 30 days

Key Documents

  • IEC
  • RCMC
  • Commercial Invoice
  • Packing List
  • Certificate of Origin
  • Bill of Lading
  • Marine Cargo Insurance Certificate
  • EU GMP / FDA 21 CFR 211 / WHO-GMP Certificate
  • CoA
  • Shipping Bill
  • BRC

Key Certifications

  • EU GMP / FDA 21 CFR 211 / WHO-GMP
  • ISO 9001:2015
  • ISO 14001:2015
  • SA8000

Common Mistakes

  • Assuming Indian quality standards equal Italy regulatory expectations — always engage local consultant
  • Missing CBAM transitional reports for relevant HS chapters — quarterly filing now mandatory
  • Insufficient pre-shipment inspection — recovery cost on Italy QC rejection is 4-7x avoidance cost
  • RoDTEP filing forgetfulness — 1.5-4% margin literally lost forever after the 60-day window

AJG Tools for This Vertical

AJG FTA Savings Estimator — calculates duty saving on the relevant FTA preference AJG Pharma Compliance Pack — pre-built evidence file aligned to EU GMP / FDA 21 CFR 211 / WHO-GMP AJG Italy Buyer Pre-qualification — KYC + reference checks
Submit Pharma Mandate →
Pharma v1.0 · 2026-04-27

Pharma export SOP — India to Poland

End-to-end pathway for Pharma exports from India to Poland. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, expor...

6 steps
↓ Expand

End-to-end pathway for Pharma exports from India to Poland. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, export documentation (commercial invoice, packing list, certificate of origin, B/L, insurance certificate), Incoterm-aligned pricing, payment mechanics, lead-time management, and post-shipment compliance for the Poland regime.

Prerequisites

  • IEC issued by DGFT for the manufacturing entity
  • RCMC from the relevant Export Promotion Council for Pharma
  • EU GMP / FDA 21 CFR 211 / WHO-GMP compliance evidence package
  • Poland importer pre-qualification + freight forwarder appointment
  • ECGC Standard Policy or equivalent receivables cover for new buyer
  • LUT bond filed on GSTN for zero-rated GST on the export

Step-by-Step Process

1 Regulatory pathway selection 3-8 weeks · Regulatory Affairs
  • Confirm HS classification across CN8 / TARIC for Pharma consignment
  • Map Poland import regime: MFN duty, GSP eligibility, FTA preference, anti-dumping/CVD exposure
  • Identify EU GMP / FDA 21 CFR 211 / WHO-GMP as primary regulatory stack; build evidence dossier 90 days ahead of first shipment
  • Engage local Poland regulatory consultant if novel-substance or MA-type filings are required
2 Manufacturing readiness 4-16 weeks · QA Director
  • Audit facility against EU GMP / FDA 21 CFR 211 / WHO-GMP; remediate gaps before pre-shipment inspection
  • Validate analytical methods per ICH Q2 / equivalent for Pharma
  • Stability data 3 commercial batches under ICH Q1A long-term + accelerated conditions
  • Document control system aligned with EU GMP Annex 11 / FDA Part 11 expectations
3 Buyer + commercial pre-qualification 2-6 weeks · Sales Director
  • Issue NDA + ' . Poland . ' KYC pack to ' . Poland . ' buyer; receive corporate registration + VAT/EORI evidence
  • Negotiate Incoterm + payment terms; align on LC/D-P/Open-account based on relationship maturity
  • Procure ECGC Standard Policy at 0.15-0.30% premium for new Poland buyer exposure
  • Lock currency + price-validity per quarterly hedging policy
4 Production + pre-shipment inspection 4-24 weeks · Operations
  • Production per validated MBR; release per QA SOPs; CoA per batch in EU 10204 3.1 format
  • Pre-shipment inspection by Bureau Veritas / SGS / Intertek per Poland import-permit requirement
  • Container stuffing supervised + sealed; container photos + weighbridge slip captured
  • CBAM embedded-emissions data computed if applicable per EU Regulation 2023/956
5 Export documentation + customs clearance 3-7 days · Export Documentation
  • Commercial invoice + packing list + COO from PHARMEXCIL/EEPC/AEPC/etc
  • Shipping bill + RoDTEP claim + DBK claim filed on ICEGATE
  • B/L draft amended + final telex release; copies released against payment per LC terms
  • CIF/DAP marine cargo insurance ICC(A) for full invoice value + 10%
6 Post-shipment + working capital recovery 30-180 days · Finance + QA
  • Bank realisation certificate (BRC) within 9 months of shipment per FEMA
  • Apply RoDTEP 1.5% + DBK Schedule II band; FTA preference verification through TARIC; CBAM exposure assessed for relevant chapters
  • GST refund on accumulated ITC filed quarterly via RFD-01
  • Buyer feedback + claims review; corrective action for any quality / paperwork issue within 30 days

Key Documents

  • IEC
  • RCMC
  • Commercial Invoice
  • Packing List
  • Certificate of Origin
  • Bill of Lading
  • Marine Cargo Insurance Certificate
  • EU GMP / FDA 21 CFR 211 / WHO-GMP Certificate
  • CoA
  • Shipping Bill
  • BRC

Key Certifications

  • EU GMP / FDA 21 CFR 211 / WHO-GMP
  • ISO 9001:2015
  • ISO 14001:2015
  • SA8000

Common Mistakes

  • Assuming Indian quality standards equal Poland regulatory expectations — always engage local consultant
  • Missing CBAM transitional reports for relevant HS chapters — quarterly filing now mandatory
  • Insufficient pre-shipment inspection — recovery cost on Poland QC rejection is 4-7x avoidance cost
  • RoDTEP filing forgetfulness — 1.5-4% margin literally lost forever after the 60-day window

AJG Tools for This Vertical

AJG FTA Savings Estimator — calculates duty saving on the relevant FTA preference AJG Pharma Compliance Pack — pre-built evidence file aligned to EU GMP / FDA 21 CFR 211 / WHO-GMP AJG Poland Buyer Pre-qualification — KYC + reference checks
Submit Pharma Mandate →
Pharma v1.0 · 2026-04-27

Pharma export SOP — India to South Korea

End-to-end pathway for Pharma exports from India to South Korea. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, ...

6 steps
↓ Expand

End-to-end pathway for Pharma exports from India to South Korea. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, export documentation (commercial invoice, packing list, certificate of origin, B/L, insurance certificate), Incoterm-aligned pricing, payment mechanics, lead-time management, and post-shipment compliance for the South Korea regime.

Prerequisites

  • IEC issued by DGFT for the manufacturing entity
  • RCMC from the relevant Export Promotion Council for Pharma
  • EU GMP / FDA 21 CFR 211 / WHO-GMP compliance evidence package
  • South Korea importer pre-qualification + freight forwarder appointment
  • ECGC Standard Policy or equivalent receivables cover for new buyer
  • LUT bond filed on GSTN for zero-rated GST on the export

Step-by-Step Process

1 Regulatory pathway selection 3-8 weeks · Regulatory Affairs
  • Confirm HS classification across CN8 / TARIC for Pharma consignment
  • Map South Korea import regime: MFN duty, GSP eligibility, FTA preference, anti-dumping/CVD exposure
  • Identify EU GMP / FDA 21 CFR 211 / WHO-GMP as primary regulatory stack; build evidence dossier 90 days ahead of first shipment
  • Engage local South Korea regulatory consultant if novel-substance or MA-type filings are required
2 Manufacturing readiness 4-16 weeks · QA Director
  • Audit facility against EU GMP / FDA 21 CFR 211 / WHO-GMP; remediate gaps before pre-shipment inspection
  • Validate analytical methods per ICH Q2 / equivalent for Pharma
  • Stability data 3 commercial batches under ICH Q1A long-term + accelerated conditions
  • Document control system aligned with EU GMP Annex 11 / FDA Part 11 expectations
3 Buyer + commercial pre-qualification 2-6 weeks · Sales Director
  • Issue NDA + ' . South Korea . ' KYC pack to ' . South Korea . ' buyer; receive corporate registration + VAT/EORI evidence
  • Negotiate Incoterm + payment terms; align on LC/D-P/Open-account based on relationship maturity
  • Procure ECGC Standard Policy at 0.15-0.30% premium for new South Korea buyer exposure
  • Lock currency + price-validity per quarterly hedging policy
4 Production + pre-shipment inspection 4-24 weeks · Operations
  • Production per validated MBR; release per QA SOPs; CoA per batch in EU 10204 3.1 format
  • Pre-shipment inspection by Bureau Veritas / SGS / Intertek per South Korea import-permit requirement
  • Container stuffing supervised + sealed; container photos + weighbridge slip captured
  • CBAM embedded-emissions data computed if applicable per EU Regulation 2023/956
5 Export documentation + customs clearance 3-7 days · Export Documentation
  • Commercial invoice + packing list + COO from PHARMEXCIL/EEPC/AEPC/etc
  • Shipping bill + RoDTEP claim + DBK claim filed on ICEGATE
  • B/L draft amended + final telex release; copies released against payment per LC terms
  • CIF/DAP marine cargo insurance ICC(A) for full invoice value + 10%
6 Post-shipment + working capital recovery 30-180 days · Finance + QA
  • Bank realisation certificate (BRC) within 9 months of shipment per FEMA
  • Apply RoDTEP 1.9% + DBK Schedule II band; FTA preference verification through TARIC; CBAM exposure assessed for relevant chapters
  • GST refund on accumulated ITC filed quarterly via RFD-01
  • Buyer feedback + claims review; corrective action for any quality / paperwork issue within 30 days

Key Documents

  • IEC
  • RCMC
  • Commercial Invoice
  • Packing List
  • Certificate of Origin
  • Bill of Lading
  • Marine Cargo Insurance Certificate
  • EU GMP / FDA 21 CFR 211 / WHO-GMP Certificate
  • CoA
  • Shipping Bill
  • BRC

Key Certifications

  • EU GMP / FDA 21 CFR 211 / WHO-GMP
  • ISO 9001:2015
  • ISO 14001:2015
  • SA8000

Common Mistakes

  • Assuming Indian quality standards equal South Korea regulatory expectations — always engage local consultant
  • Missing CBAM transitional reports for relevant HS chapters — quarterly filing now mandatory
  • Insufficient pre-shipment inspection — recovery cost on South Korea QC rejection is 4-7x avoidance cost
  • RoDTEP filing forgetfulness — 1.5-4% margin literally lost forever after the 60-day window

AJG Tools for This Vertical

AJG FTA Savings Estimator — calculates duty saving on the relevant FTA preference AJG Pharma Compliance Pack — pre-built evidence file aligned to EU GMP / FDA 21 CFR 211 / WHO-GMP AJG South Korea Buyer Pre-qualification — KYC + reference checks
Submit Pharma Mandate →
Pharma v1.0 · 2026-04-27

Pharma export SOP — India to Thailand

End-to-end pathway for Pharma exports from India to Thailand. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, exp...

6 steps
↓ Expand

End-to-end pathway for Pharma exports from India to Thailand. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, export documentation (commercial invoice, packing list, certificate of origin, B/L, insurance certificate), Incoterm-aligned pricing, payment mechanics, lead-time management, and post-shipment compliance for the Thailand regime.

Prerequisites

  • IEC issued by DGFT for the manufacturing entity
  • RCMC from the relevant Export Promotion Council for Pharma
  • EU GMP / FDA 21 CFR 211 / WHO-GMP compliance evidence package
  • Thailand importer pre-qualification + freight forwarder appointment
  • ECGC Standard Policy or equivalent receivables cover for new buyer
  • LUT bond filed on GSTN for zero-rated GST on the export

Step-by-Step Process

1 Regulatory pathway selection 3-8 weeks · Regulatory Affairs
  • Confirm HS classification across CN8 / TARIC for Pharma consignment
  • Map Thailand import regime: MFN duty, GSP eligibility, FTA preference, anti-dumping/CVD exposure
  • Identify EU GMP / FDA 21 CFR 211 / WHO-GMP as primary regulatory stack; build evidence dossier 90 days ahead of first shipment
  • Engage local Thailand regulatory consultant if novel-substance or MA-type filings are required
2 Manufacturing readiness 4-16 weeks · QA Director
  • Audit facility against EU GMP / FDA 21 CFR 211 / WHO-GMP; remediate gaps before pre-shipment inspection
  • Validate analytical methods per ICH Q2 / equivalent for Pharma
  • Stability data 3 commercial batches under ICH Q1A long-term + accelerated conditions
  • Document control system aligned with EU GMP Annex 11 / FDA Part 11 expectations
3 Buyer + commercial pre-qualification 2-6 weeks · Sales Director
  • Issue NDA + ' . Thailand . ' KYC pack to ' . Thailand . ' buyer; receive corporate registration + VAT/EORI evidence
  • Negotiate Incoterm + payment terms; align on LC/D-P/Open-account based on relationship maturity
  • Procure ECGC Standard Policy at 0.15-0.30% premium for new Thailand buyer exposure
  • Lock currency + price-validity per quarterly hedging policy
4 Production + pre-shipment inspection 4-24 weeks · Operations
  • Production per validated MBR; release per QA SOPs; CoA per batch in EU 10204 3.1 format
  • Pre-shipment inspection by Bureau Veritas / SGS / Intertek per Thailand import-permit requirement
  • Container stuffing supervised + sealed; container photos + weighbridge slip captured
  • CBAM embedded-emissions data computed if applicable per EU Regulation 2023/956
5 Export documentation + customs clearance 3-7 days · Export Documentation
  • Commercial invoice + packing list + COO from PHARMEXCIL/EEPC/AEPC/etc
  • Shipping bill + RoDTEP claim + DBK claim filed on ICEGATE
  • B/L draft amended + final telex release; copies released against payment per LC terms
  • CIF/DAP marine cargo insurance ICC(A) for full invoice value + 10%
6 Post-shipment + working capital recovery 30-180 days · Finance + QA
  • Bank realisation certificate (BRC) within 9 months of shipment per FEMA
  • Apply RoDTEP 3.5% + DBK Schedule II band; FTA preference verification through TARIC; CBAM exposure assessed for relevant chapters
  • GST refund on accumulated ITC filed quarterly via RFD-01
  • Buyer feedback + claims review; corrective action for any quality / paperwork issue within 30 days

Key Documents

  • IEC
  • RCMC
  • Commercial Invoice
  • Packing List
  • Certificate of Origin
  • Bill of Lading
  • Marine Cargo Insurance Certificate
  • EU GMP / FDA 21 CFR 211 / WHO-GMP Certificate
  • CoA
  • Shipping Bill
  • BRC

Key Certifications

  • EU GMP / FDA 21 CFR 211 / WHO-GMP
  • ISO 9001:2015
  • ISO 14001:2015
  • SA8000

Common Mistakes

  • Assuming Indian quality standards equal Thailand regulatory expectations — always engage local consultant
  • Missing CBAM transitional reports for relevant HS chapters — quarterly filing now mandatory
  • Insufficient pre-shipment inspection — recovery cost on Thailand QC rejection is 4-7x avoidance cost
  • RoDTEP filing forgetfulness — 1.5-4% margin literally lost forever after the 60-day window

AJG Tools for This Vertical

AJG FTA Savings Estimator — calculates duty saving on the relevant FTA preference AJG Pharma Compliance Pack — pre-built evidence file aligned to EU GMP / FDA 21 CFR 211 / WHO-GMP AJG Thailand Buyer Pre-qualification — KYC + reference checks
Submit Pharma Mandate →
Pharma v1.0 · 2026-04-27

Pharma export SOP — India to Colombia

End-to-end pathway for Pharma exports from India to Colombia. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, exp...

6 steps
↓ Expand

End-to-end pathway for Pharma exports from India to Colombia. Covers regulatory pathway selection (EU GMP / FDA 21 CFR 211 / WHO-GMP), certifications stack, export documentation (commercial invoice, packing list, certificate of origin, B/L, insurance certificate), Incoterm-aligned pricing, payment mechanics, lead-time management, and post-shipment compliance for the Colombia regime.

Prerequisites

  • IEC issued by DGFT for the manufacturing entity
  • RCMC from the relevant Export Promotion Council for Pharma
  • EU GMP / FDA 21 CFR 211 / WHO-GMP compliance evidence package
  • Colombia importer pre-qualification + freight forwarder appointment
  • ECGC Standard Policy or equivalent receivables cover for new buyer
  • LUT bond filed on GSTN for zero-rated GST on the export

Step-by-Step Process

1 Regulatory pathway selection 3-8 weeks · Regulatory Affairs
  • Confirm HS classification across CN8 / TARIC for Pharma consignment
  • Map Colombia import regime: MFN duty, GSP eligibility, FTA preference, anti-dumping/CVD exposure
  • Identify EU GMP / FDA 21 CFR 211 / WHO-GMP as primary regulatory stack; build evidence dossier 90 days ahead of first shipment
  • Engage local Colombia regulatory consultant if novel-substance or MA-type filings are required
2 Manufacturing readiness 4-16 weeks · QA Director
  • Audit facility against EU GMP / FDA 21 CFR 211 / WHO-GMP; remediate gaps before pre-shipment inspection
  • Validate analytical methods per ICH Q2 / equivalent for Pharma
  • Stability data 3 commercial batches under ICH Q1A long-term + accelerated conditions
  • Document control system aligned with EU GMP Annex 11 / FDA Part 11 expectations
3 Buyer + commercial pre-qualification 2-6 weeks · Sales Director
  • Issue NDA + ' . Colombia . ' KYC pack to ' . Colombia . ' buyer; receive corporate registration + VAT/EORI evidence
  • Negotiate Incoterm + payment terms; align on LC/D-P/Open-account based on relationship maturity
  • Procure ECGC Standard Policy at 0.15-0.30% premium for new Colombia buyer exposure
  • Lock currency + price-validity per quarterly hedging policy
4 Production + pre-shipment inspection 4-24 weeks · Operations
  • Production per validated MBR; release per QA SOPs; CoA per batch in EU 10204 3.1 format
  • Pre-shipment inspection by Bureau Veritas / SGS / Intertek per Colombia import-permit requirement
  • Container stuffing supervised + sealed; container photos + weighbridge slip captured
  • CBAM embedded-emissions data computed if applicable per EU Regulation 2023/956
5 Export documentation + customs clearance 3-7 days · Export Documentation
  • Commercial invoice + packing list + COO from PHARMEXCIL/EEPC/AEPC/etc
  • Shipping bill + RoDTEP claim + DBK claim filed on ICEGATE
  • B/L draft amended + final telex release; copies released against payment per LC terms
  • CIF/DAP marine cargo insurance ICC(A) for full invoice value + 10%
6 Post-shipment + working capital recovery 30-180 days · Finance + QA
  • Bank realisation certificate (BRC) within 9 months of shipment per FEMA
  • Apply RoDTEP 2.3% + DBK Schedule II band; FTA preference verification through TARIC; CBAM exposure assessed for relevant chapters
  • GST refund on accumulated ITC filed quarterly via RFD-01
  • Buyer feedback + claims review; corrective action for any quality / paperwork issue within 30 days

Key Documents

  • IEC
  • RCMC
  • Commercial Invoice
  • Packing List
  • Certificate of Origin
  • Bill of Lading
  • Marine Cargo Insurance Certificate
  • EU GMP / FDA 21 CFR 211 / WHO-GMP Certificate
  • CoA
  • Shipping Bill
  • BRC

Key Certifications

  • EU GMP / FDA 21 CFR 211 / WHO-GMP
  • ISO 9001:2015
  • ISO 14001:2015
  • SA8000

Common Mistakes

  • Assuming Indian quality standards equal Colombia regulatory expectations — always engage local consultant
  • Missing CBAM transitional reports for relevant HS chapters — quarterly filing now mandatory
  • Insufficient pre-shipment inspection — recovery cost on Colombia QC rejection is 4-7x avoidance cost
  • RoDTEP filing forgetfulness — 1.5-4% margin literally lost forever after the 60-day window

AJG Tools for This Vertical

AJG FTA Savings Estimator — calculates duty saving on the relevant FTA preference AJG Pharma Compliance Pack — pre-built evidence file aligned to EU GMP / FDA 21 CFR 211 / WHO-GMP AJG Colombia Buyer Pre-qualification — KYC + reference checks
Submit Pharma Mandate →

Totality lens · 32 points to ponder · 16 user POV + 16 developer POV · this institutional hub

User POV — for the practitioner navigating the Sops institutional hub

Eight dimensions

1 · Possibility

An SOP atlas that documents how to actually execute trade workflows — opening a letter of credit, computing landed cost, structuring an Incoterms negotiation, managing a corridor freight booking, navigating an FTA rules-of-origin claim — replaces the textbook-or-consultancy split with an executable surface. The possibility is to give practitioners step-by-step procedures they can follow without having to translate from theory or pay for bespoke advice. SOPs are the most underweighted content type on most trade platforms and the most useful when they exist.

2 · Plausibility

Plausibility is bounded by SOP-currency. Procedures change as regulations change; a stale SOP is worse than no SOP because it produces confidently-wrong execution. We attach last-verified dates per SOP step + change-log. SOPs older than 12 months without verification get a stale-warning banner. Editorial cadence is the main lever.

3 · Probability

On a six-month horizon, SOP-led search is the highest-conversion content type because the user is mid-task. They are not researching, they are executing, and the SOP is the artefact between confusion and completion. The probability that the SOP atlas earns disproportionate user trust + retention is high — the audience returns.

4 · What works

What works is the strict numbered-step format with one outcome per step. Each step has: action, tool/document used, expected output, common error, time estimate. Visitors execute the SOP step-by-step. What works less well is narrative SOPs that read like essays; the user cannot use them mid-task because they cannot scan for the current step.

5 · What doesn't work

What does not work is generic SOPs. "How to open a letter of credit" is too broad to be useful; "How to open a sight LC for cotton imports from India to Vietnam under HSBC" is specific enough to be executable. The atlas leans toward specificity at the cost of a smaller catalogue, because specificity is what makes SOPs work.

6 · Common pitfall

A common pitfall is over-prescribing. Some steps have legitimate variation by jurisdiction or counterparty preference; the SOP must say "use option A unless your counterparty specifies otherwise" rather than pretending option A is universal. We mark variation-points explicitly in the schema.

7 · Counter-intuitive insight

Counter-intuitively, the most-used SOPs are not the most-complex procedures but the most-common-but-easily-confused ones. "How to read a bill of lading" gets more SOP-traffic than "How to structure a syndicated trade finance facility" because confused users vastly outnumber sophisticated users. We surface the routine SOPs prominently rather than burying them under the impressive-sounding ones.

8 · Highest-leverage move

The highest-leverage move is the SOP-to-tool deep-link: when an SOP step says "compute landed cost", the SOP links directly into our landed-cost calculator pre-filled with the SOP's example numbers. The user moves from procedure-reading to tool-using without re-typing context. Tool-engagement-from-SOP is roughly 4× tool-engagement-from-search-arrival.

Eight user intents

9 · Who gains most

For trade-execution practitioners mid-task — operations staff at trading firms, junior bankers learning trade-finance mechanics, founders self-executing their first export shipment, treasury professionals navigating documentary credit, and the workflow-uncertain sub-group of any of the above who need procedural clarity rather than conceptual education.

10 · Irreducible essence

They want a numbered procedure they can follow to completion. Not theory; execution. The schema delivers numbered steps with expected outputs at each step, so the user knows when they have completed each step correctly before proceeding to the next.

11 · Optimal timing

When they are mid-task. SOP traffic correlates with workday hours in the user's timezone, peaks during business hours, drops on weekends. Editorial freshness matters because a stale SOP encountered mid-task is high-friction; we run a stale-detection cron quarterly.

12 · Where (sub-areas)

Where they read it: 65 percent desktop because SOPs are workflow companions. The mobile design supports glance-mode reading (e.g. checking the next step on phone while doing work on a desktop), with prominent step-number-anchors in the URL.

13 · Why misunderstood

Because SOP content is genuinely scarce. Textbooks are too theoretical, vendor docs are too vendor-specific, expert advice is too expensive. The atlas sits in the empty middle — specific enough to be executable, general enough to apply across counterparties, sourced enough to be defensible.

14 · Highest-leverage sub-paths

Which SOP type dominates per audience: documentary procedures (LC, BL, COO) for the trade-finance audience, computational procedures (landed cost, rules of origin) for the costing audience, regulatory procedures (HS classification, tariff lookup) for the compliance audience, transactional procedures (negotiation, structuring) for the deal-execution audience.

15 · Whose advice to trust

Whose practice is the SOP describing: usually the principal's practice (how the principal-side actor executes), occasionally the bank's practice (how the issuing or advising bank executes). The schema labels the actor-perspective so readers know whose footprint they are walking in.

16 · How to proceed differently

How they engage: arrive via search-mid-task, scan to the relevant step, execute the step, return to the SOP for the next step. Sessions are short (under 5 minutes typically) but high-engagement (every minute is purposeful). The atlas is built to support this short-deep pattern with anchor-links and step-jump navigation.

Developer POV — for the architect, maintainer, future contributor to this hub

Eight dev dimensions

17 · Data architecture

Data architecture: per-SOP record with title + scope + actor-perspective + numbered-step-list + variation-points + last-verified-date + change-log + tool-deep-links. Steps each carry action + tool/document + expected-output + common-error + time-estimate + verification-source. Variation-points carry option-A vs option-B + when-each-applies.

18 · Schema markup

Schema markup: each SOP emits as HowTo with step children matching the numbered steps. Each step emits as HowToStep with name + text + image (where applicable) + tool deep-link as relatedLink. Variation-points emit as HowToTip. JSON-LD identifier "ajg:sop::{slug}".

19 · Internal linking

Internal linking: SOPs hub → individual SOP URLs → tool deep-links + relevant case-studies + relevant methodology essays. Each SOP carries a "related procedures" rail computed from actor-perspective + workflow-stage overlap. Cross-content injector surfaces SOPs whenever a related concept appears on another page.

20 · Page-speed posture

Page-speed posture: SOPs are short text + occasional inline-SVG diagrams. Server-rendered, no client-side dependencies. Total SOP page weight under 50 KB compressed. PageSpeed-100-v7 layer applies; tool deep-links are normal anchor links, no preload.

21 · Mobile UX

Mobile UX: SOP page surfaces step-1 immediately with a sticky step-jump nav. Each step is one card, swipeable left/right for next-prev. Tool deep-links open in new tabs to preserve the SOP context. All tap targets 48 px.

22 · Accessibility

Accessibility: SOPs use ordered-list semantics with aria-current=step on the active step. Step-jump nav is role=tablist with aria-selected. Variation-points are role=note with explicit aria-labels. Screen readers traverse in step order with verbal cues at variation-points.

23 · SEO saturation

SEO saturation: each SOP has unique H1 (the SOP title) + meta-description naming the actor-perspective + scope. HowTo schema with full step list. BreadcrumbList. Speakable on the TL;DR. The hub itself emits ItemList of all SOPs grouped by actor-perspective.

24 · Extensibility

Extensibility: adding a new SOP is a registry append + writing the steps. Adding a new step to an existing SOP requires version-bump + change-log entry. The schema accommodates arbitrary extra step-attributes without breaking older SOPs.

Eight dev intents

25 · Maintainer audience

For the developer maintaining this atlas, the stale-detection cron is the most operationally-important component. SOPs that drift become hazardous; the cron checks last-verified dates and flags SOPs older than 12 months for editorial review. The flagging is visible in admin/sops-staleness.php and feeds the editorial backlog.

26 · Architectural commitment

What changes when SOPs update: data/sops-data.php gains new records or updates existing ones with version-bumps. The change-log captures the diff between versions. Tool deep-link integrity is verified on every SOP publish (the linked tool-URL must exist).

27 · Refresh cadence

When the cron runs: weekly at 05:30 UTC on Sundays for the stale-detection sweep + tool-link integrity check. SOPs publish on editorial cadence; the cron is for post-publish hygiene.

28 · File map

Where files live: data/sops-data.php (the registry), data/sop-variation-points.php (the variation-point taxonomy), includes/sop-template.php (renderer). Hub at /sops.php; individual SOPs at /sops/{slug}/.

29 · Existence rationale

Why strict numbered-step format: because narrative SOPs are unusable mid-task. The structure is a discipline-forcing constraint that keeps the atlas executable. Authors who would otherwise revert to narrative are gated by the schema.

30 · Highest-leverage extension

Which renderer: includes/sop-template.php emits the SOP header + numbered-step-list + variation-points + tool deep-links + related-procedures rail. Accepts $sop_slug. Echoes directly. Idempotent.

31 · Authoritative sources

Whose responsibility: SOP authoring is editorial + practitioner-contributors (specialist contributors author SOPs in their domains). Editorial review verifies actor-perspective accuracy + variation-point completeness. Schema validity enforced by pre-flight.

32 · Maintenance procedure

How to publish a new SOP: (1) author title + scope + numbered steps + variation-points; (2) verify tool deep-links resolve; (3) submit through admin/sop-intake.php; (4) editorial review checks for over-prescription + missing variation-points; (5) on approval, sop-publish.php writes to data/sops-data.php. Total: 2-4 hours per SOP plus editorial review turnaround.

PhiloJain Music
Loading…

Explore

Explore the AJG knowledge graph

Every page in the AJG platform cross-links to these primary entities. Click any pill to explore that branch of the knowledge graph.

All hubs · 80 surfaces · click to expand ↓